University of Nebraska Medical Center

DigitalCommons@UNMC
Theses & Dissertations

Graduate Studies

Spring 5-7-2016

Spatiotemporal Control of Staphylococcus aureus Biofilm
Development
Derek E. Moormeier
University of Nebraska Medical Center

Follow this and additional works at: https://digitalcommons.unmc.edu/etd
Part of the Bacteriology Commons

Recommended Citation
Moormeier, Derek E., "Spatiotemporal Control of Staphylococcus aureus Biofilm Development" (2016).
Theses & Dissertations. 65.
https://digitalcommons.unmc.edu/etd/65

This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It
has been accepted for inclusion in Theses & Dissertations by an authorized administrator of
DigitalCommons@UNMC. For more information, please contact digitalcommons@unmc.edu.

i

Spatiotemporal Control of Staphylococcus aureus
Biofilm Development
by

Derek E. Moormeier
A DISSERTATION
Presented to the Faculty of the University of Nebraska Graduate College in
Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy

Pathology and Microbiology Graduate Program

Under the Supervision of Professor Kenneth W. Bayles

University of Nebraska Medical Center
Omaha, NE

February 2015
Supervisory Committee:
Paul D. Fey, Ph.D.
Marilynn A. Larson, Ph.D.
Jeffrey L. Bose, Ph.D.
Bradley E. Britigan, M.D.
Laurey Steinke, Ph.D.

ii
Spatiotemporal Control of Staphylococcus aureus Biofilm Development
Derek E. Moormeier, Ph.D.
University of Nebraska Medical Center, 2015
Supervisor: Kenneth W. Bayles, Ph.D.
Chronic

biofilm-related

infections

caused

by

the

human

pathogen

Staphylococcus aureus often lead to significant increases in morbidity and mortality in
both hospital- and community-associated settings. Typically, S. aureus biofilm
development occurs in three stages: 1) attachment, 2) tower maturation, and 3)
dispersal. Here, utilizing BioFlux1000 time-lapse microscopy we have expanded upon
these fundamental stages of biofilm development and also unveiled and characterized
two additional stages (multiplication and exodus).
The attachment and multiplication stages were shown to be protease sensitive
but independent of most cell surface-associated proteins. Following multiplication, an
exodus of the biofilm population that followed the transition of the biofilm to DNase I
sensitivity

was

demonstrated.

Furthermore,

disruption

of

the

gene

encoding

staphylococcal nuclease (nuc) abrogated this exodus event, causing hyper-proliferation
of the biofilm and disrupting tower development. Prior to exodus, cells carrying a
Pnuc::gfp promoter fusion demonstrated Sae-dependent expression, but only in a
subpopulation of cells. Additionally, we also determined that other Sae-regulated genes
demonstrated unique Sae-dependent stochastic expression patterns. Collectively, these
results suggest the presence of a Sae-controlled nuclease-mediated exodus of a biofilm
subpopulation that is required for tower development as well as controlling the stochastic
expression of Sae-regulated factors.
The cidABC and lrgAB operons have previously been shown to play specific
roles in controlled cell death and release of extracellular DNA (eDNA) during biofilm
maturation. Although the exact mechanisms controlling the cid and lrg operons have yet
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to be completely elucidated, the expression of the operons is dependent on altered
metabolic cues as a result of overflow metabolism. We hypothesized that the differential
expression of the cid and lrg operons within a biofilm is a function of the metabolic
heterogeneity

found

within

different

biofilm

microenvironments.

Time-lapse

epifluorescent images indicate that expression of these operons is specific to distinct
regions of a growing biofilm.

Additionally, these results revealed the existence of

different tower types, possibly reflecting their different functional roles in development.
Altogether, nuclease-mediated eDNA degradation modulates the biofilm to produce two
distinct towers that there are both spatially and temporally different between compared
to the rest of the biofilm.
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CHAPTER I:
INTRODUCTION - LITERATURE REVIEW
Staphylococcus aureus
Epidemiology
The highly virulent human pathogen, Staphylococcus aureus, is a facultative
Gram-positive bacterium that can colonize several places on the human body including
skin, throat, axilla, perirectal, groin and the nasopharynx (1-3). In fact, it is thought that
S. aureus colonizes more than 30% of the human population’s nares (4), and that
colonization of the nares is increasingly becoming a risk factor for more serious
infections. While S. aureus is considered a commensal organism, it is also considered
an opportunistic pathogen because it can cause a plethora of both community and
healthcare-associated infections ranging from skin and soft tissue infections to more
serious

life-threatening

diseases

such

as

bacteremia,

infective

endocarditis,

osteomyelitis, necrotizing pneumonia, and septic arthritis under the right conditions (5).
In fact, S. aureus is now the leading cause of infective endocarditis in the industrialized
world (6), and a prominent cause of osteomyelitis (5). Collectively, in the United States
alone, S. aureus is one of the leading causes of all community and healthcareassociated infections and has caused increased mortality rates and nearly doubles the
hospitalization time when compared to normal hospital stays (7). As a result, the
prevalence of these diseases has led to increased costs associated with S. aureus
infections over the past decade, estimated to be near $450 million annually (8, 9). Thus,
it is obvious why S. aureus has become one of the most notorious ‘superbugs’ not only
in the United States, but all across the industrialized world.
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Antibiotic Resistance
In order to cause so many different types of diseases, S. aureus has developed
some unique virulence factors that aid in its survival and pathogenesis including toxin
production, secreted enzyme production, host binding proteins, and biofilm formation.
However, one of the most prominent capabilities is the ability of the organism to acquire
antibiotic resistance. Starting in the 1940’s, a plasmid-encoded penicillinase plasmid
emerged, producing penicillin-resistant strains in several hospitals (10, 11). By the
1950’s and 1960’s as the penicillin-resistant strains continued to spread via the 80-81
phage-type, penicillin-resistant strains of S. aureus had become a pandemic (12), and it
was not until the development of methicillin in the early 1960’s that penicillin-strains were
diminished greatly. However, the emergence of methicillin-resistant S. aureus,
commonly known as MRSA, followed the wide-spread use of methicillin shortly
thereafter (13). For decades following, MRSA strains have remained a prevalent cause
of S. aureus-related infections, and in the 1990s, the emergence of community-acquired
MRSA (CA-MRSA) strains has sparked an epidemic in the United States (14). Typically,
disease manifestation of CA-MRSA strains appear to primarily cause skin and soft tissue
infections in the form of abscess formation or cellulitis in 90% of the individuals with CAMRSA infections (15, 16). In the last decades because CA-MRSA related infections
remain such a persistent problem, the increased use of vancomycin, one of the last
effective antibiotics against MRSA, has also led to the emergence of vancomycinintermediate and vancomycin-resistant (VISA and VRSA) S. aureus strains (17, 18). Due
to the constant rise in CA-MRSA related infections and the reoccurring emergence of
different types of antibiotic resistance, it is becoming apparent that S. aureus is an
astonishingly adaptable pathogen that we must continue to monitor and study.
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Virulence Factors
Toxins
A major virulence factor that allows S. aureus to cause so many different types of
diseases is its ability to produce toxins. Indeed, it is one of the most distinguishable
capabilities that separate S. aureus from most other human pathogens. While several
bacterial species can usually produce one or two types of toxins, S. aureus produces
several categories of toxins that range in function from membrane damaging to
interfering with the function of host cell receptors (19). Perhaps, the most well-known
toxins are the receptor-mediated membrane damaging toxins that cause cytolysis of
several host cell types by forming pores in the cell membrane. Within this group, the
most well-known and well-studied is alpha-toxin (20), which can cause lysis of red blood
cells and leukocytes (21) by interacting with the A Disintegrin And Metalloprotease 10
(ADAM10) receptor found on the host cell surfaces (22). Likewise, S. aureus also
produces a similar group of host cell receptor-mediated pore forming toxins known as
the bi-component toxin family consisting of the Panton-Valentine leukocidins (PVL), the
leukocidins LukAB (LukGH) and LukDE, and the gamma-toxins (HlgA, HlgB, HlgC,
gamma-hemolysin) (23-26). Like receptor-mediated pore forming toxins, a group of nonreceptor-mediated membrane damaging toxins called the phenol soluble modullins
(PSMs) has recently been discovered. This group of non-specific pore forming toxins
consists of three groups of δ-toxin, PSMα, and PSMβ all of which have differing
contributions to pathogenesis via non-specific cytolytic activity (27).
The second most well-known group of toxins produced by S. aureus is the toxins
that interfere with specific receptor functions on host cells. This group is largely
comprised of the superantigen group of toxins: enterotoxins and the toxic shock
syndrome toxin (TSST), and the chemotaxis inhibitory protein of S. aureus (CHIPS),
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which has been shown to function as an immune suppresser by blocking activation of
the complement system (28). While the exact mechanism of how these toxins work
remain largely undetermined, the approximately 20 enterotoxin and enterotoxin-like
proteins produced by S. aureus have been shown to be involved in disturbing proper
intestinal function and causing food borne illnesses such as vomiting and diarrhea (29).
While it can also cause food borne illnesses, the superantigen TSST is primarily known
for its function in causing toxic shock syndrome (30, 31). Like the other enterotoxins, it is
also thought that TSST by-passes normal antigen presentation by binding MHC II
proteins and initiating cytokine release (32).
Secreted Enzymes
Another major component included in the arsenal of virulence factors that are
produced by S. aureus is the numerous secreted enzymes that enable degradation of
host components or interfere with host molecular signaling. Although Staphylococci
produce various types of secreted enzymes including proteases, coagulases, kinases,
and nucleases, perhaps, the most studied are the ten secreted proteases because of
their various roles in aiding pathogenesis. These ten proteases include seven serine
proteases (SspA and SplABCDEF), two cysteine proteases (the Staphopains ScpA and
SspB), and a metalloprotease (Aureolysin). In combination with the reports of affecting
biofilm integrity in vitro (discussed below) (33), in some instances, the proteases have
been shown to be important for causing infections. While the basic function of the
proteases is to cleave both self and host proteins, the overall process in which the
proteases affect biofilm maturation and pathogenesis remains unclear given the myriad
of targets of each individual protease. One thought is that the proteases may degrade
the host proteins for nutrient acquisition to aid in growth under proteinaceous-rich
environments (34). However, a complete knock out of all ten proteases also showed an
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increase in S. aureus extracellular virulence factor production and an increase in
mortality in a systemic mouse model infection (34). Further complicating the
understanding of protease contribution to pathogenesis is that in some cases individual
proteases must be auto-activated (35, 36) or rely on a proteolytic cleavage cascade
activation (37, 38). Nonetheless, it is apparent that the production of the secreted
proteases plays a complex role in S. aureus pathogenesis that must continue to be
evaluated.
Although not as well studied, other secreted enzymes also have important
functions in pathogenesis in a number of different ways. For example, the two known
coagulases, staphylocoagulase and van Willebrand factor (vWF), produced by
staphylococci are important for forming clots in the blood plasma, inhibiting phagocytosis
in abscess formation (39), and enhancing adhesion in catheter biofilm-associated
infections (40). It is thought that the coagulases function by binding and activating
prothrombin and converting fibrinogen to fibrin leading to the formation of the fibrin blood
clots (41). And while these appear to be the main functions, staphylocoagulase has also
been implicated in the formation of S. aureus biofilms grown under shear stress
conditions (discussed in biofilm section) (42)
On the other hand, staphylokinase is thought to degrade fibrin clots generated
during a S. aureus infection to maintain localization of the infection and allow bacterial
invasion into deeper tissues (43, 44). It does so by activating plasminogen and
converting it to plasmin, which may enhance lysis of surrounding host tissues allowing
bacterial invasion. Additionally, it also aids in S. aureus infections by cleaving and
inactivating the complement factor, C3b (45).
Lastly, while both S. aureus nucleases have continuously been shown to have a
function in modulating biofilm formation (discussed below), the secreted nuclease (Nuc)
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has also been shown to have a function in degrading neutrophil extracellular traps
(NETs) during an S. aureus infection (46, 47). Further evidence for a nuclease as
potential virulence factor is the recent data demonstrating a decreased bacterial load per
organ in in mouse peritonitis model (48), although the exact mechanism contributing to
this phenotype is not well understood.

Bacterial Biofilms
In contrast to laboratory conditions, bacteria are rarely grown in a planktonic
state under nutrient rich conditions. Rather, they are almost exclusively living in nutrientdeficient environments in multicellular aggregations of cells called biofilms (49, 50). In
order to form biofilms, bacteria must generate a self-produced extracellular matrix (ECM)
composed of proteins, carbohydrates, and/or extracellular DNA (eDNA) (51). The ECM
encases the cells in a sticky agglomeration that facilitates survival in hostile or extreme
environments including adverse conditions of temperature, pH, therapeutic treatments,
and/or immune cells within a host (52).
To allow survival in such harsh conditions, a fascinating ability of bacterial
biofilms is the capability to allow single-celled organisms to assume multicellular group
behavior mediated by complex regulatory networks that react to changes in the
surrounding environmental or biofilm conditions (53). Indeed, multicellularity has been
shown in several different bacterial species and provides the organism benefits that it
would otherwise not typically have including division of labor into distinct cell types (54).
A recent example of this is the non-pathogenic Bacillus subtilis, which distinctly
differentiates into separate cell types. More specifically, B. subtilis has been shown to
determine differential fates of cells involved in motility, matrix production, sporulation,
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cell death, cannibalism and competence based on environmental conditions and
correlating with spatiotemporal control within a developing biofilm (55, 56). Additionally,
although not known for cell differentiation during biofilm formation, the soil predator
Myxococcus xanthus has also been shown to coordinate unparalleled cell differentiation
when ‘swarming’ and forming fruiting body structures when preying on other soil-dwelling
organisms (57). In addition, individual cells within a biofilm have also been shown to
differentiate and demonstrate genetic and physiologic heterogeneity based on
differences in microscale chemical gradients, local environmental conditions, and
stochastic gene expression (58).

Although complex and varying across bacterial

species, the conditions within the biofilm and regulatory processes are largely sensed
and coordinated by two-component (59) and quorum sensing systems. In particular, the
quorum sensing systems enable cells to communicate to each other to coordinate cell
differentiation and gene expression based on self-produced cell density signals known
as autoinducers (60). Overall, it is abundantly clear that biofilms that enable
multicellularity processes that are dependent on a plethora of environmental sensing and
quorum sensing mechanisms.
Typically, bacterial biofilm development is described in three successive stages:
1. attachment, 2. accumulation/maturation, and 3. detachment/dispersal (53, 61). During
the initial attachment stage, planktonic cells adhere to a biotic or abiotic surface and
proliferate into sticky aggregations called towers (also known as microcolonies). As
these aggregations develop, bacterial cells produce an ECM that serves as a scaffold to
determine three-dimensional architecture. Upon reaching a specific density, a
mechanism is triggered to initiate ECM modulation to allow cells embedded within the
biofilm ECM to detach and disperse to seed other environment to reinitiate biofilm
development.
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In recent years, bacterial biofilms produced by human pathogens have become
particularly important to study due to their increase recalcitrance, to not only the host
immune system and antimicrobial peptides (62), but to antibiotics and other therapeutic
treatment (63, 64). Despite the prevalence of these biofilm-associated infections, the
molecular mechanisms that control the steps of biofilm development are still being
investigated.
Staphylococcal Biofilms
Like other human pathogens, Staphylococcus aureus has progressively become
notorious for causing chronic nosocomial infections due to its ability to resist therapeutic
treatment by forming biofilms on both indwelling medical devices including implanted
artificial heart valves, pacemakers, catheters and joint prosthetics (65, 66). Indeed,
nearly half of all nosocomial infections are associated with indwelling device infections
(67). In addition, S. aureus has also developed the ability to form biofilms on host bone
tissue and heart valves possibly leading to osteomyelitis and endocarditis infections,
respectively (68). To cause such persistent infections, not only does the ECM of S.
aureus biofilms provide a physical barrier to protect staphylococcal cells from antibiotic
therapy and host immune system infiltration, but recent data also suggest that S. aureus
biofilms actively skew the immune system limiting macrophage invasion in vivo and
contributing to bacterial persistence (69-73). In addition, the metabolic state of the cell
also enables persistence of bacterial cell in response to antibiotic treatment (74). Since
antibiotics generally target metabolically active dividing cells, the formation of
metabolically dormant cells known as persisters add another component to S. aureus
biofilms abilities to resist antibiotic treatment independent of other encoded antibiotic
resistance mechanisms (75). Thus, a continued understanding of the development of
staphylococcal biofilms at the molecular level remains a high priority.
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Stages of Staphylococcus aureus Biofilm Development
Attachment Stage
Like other bacterial biofilm development, S. aureus is thought to form biofilms in
three

sequential

stages:

1.

attachment,

2.

accumulation/maturation,

and

3.

dispersal/detachment (76). During attachment, planktonic cells adhere to either abiotic or
biotic surfaces. When attaching to biotic surfaces such as matrix components of the host
tissue, S. aureus is thought to utilize a variety of different surface proteins specific for the
host matrix substrates. A well-characterized group of surface anchored proteins known
as the microbial surface components recognizing adhesive matrix molecules
(MSCRAMMs) facilitate attachment to host matrix component such as fibronectin,
fibrinogen, collagen, and cytokeratin (77). Specific examples of MSCRAMMs include the
fibronectin-binding proteins (FnBPA and FnBPB) (78), the serine-aspartate repeat family
proteins (SdrC, SdrD, and SdrE) (79, 80), the clumping factors (ClfA and ClfB) (81, 82),
the collagen adhesin (83), and the bone sialo-binding protein (Bbp) (84). Additionally,
while the primary purpose of MSCRAMMs is to bind host proteins and potentially initiate
biofilm formation, it is also becoming more prevalent that these proteins also have
additional functions which aid in pathogenesis including immune evasion (77).
S. aureus produces several surface proteins such as the MSCRAMMs that play a
significant function in adhesion and initial accumulation to host matrix components, yet,
more recent data suggests that these proteins play a less significant function in
attachment to abiotic materials such as polystyrene or a glass. This is not a surprise
considering the host matrix substrates important for MSCRAMM binding are absent
when cells are binding to these types of abiotic surfaces. Recently, three different types
of molecules have been implicated in binding to abiotic surfaces. First, a mutation in the
Agr quorum sensing circuit, typically known for its function in biofilm dispersal by
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regulating the PSMs (discussed below), was previously shown to inhibit attachment to
polystyrene by preventing hydrophobic interactions between the cell and the polymer
surface via limited production of the PSM δ-toxin (85). Second, like δ-toxin, the major
autolysin AtlA has also been proposed to aid in cell attachment, (86, 87) although the
multi-functionality of this protein makes it difficult to determine the exact mechanism of
attachment. Lastly, there is some data to suggest that S. aureus teichoic aids also have
a function attachment mediated by charge interactions with an abiotic surface (88).
Accumulation/Maturation Stage
During the accumulation/maturation stages of biofilm development, S. aureus
begins to create the ECM composed of polysaccharide intercellular adhesin (PIA),
eDNA, and/or proteins which allow cells within the biofilm to stick together and form
three-dimensional structures. Possibly the most studied of these ECM components, PIA,
produced by the icaADBC operon, has been shown numerous times to have a function
in the accumulation and maturation of S. aureus biofilms (89-91). Yet, it appears to be
strain- or condition-specific, given the number of strains that have also been shown to
form PIA-independent biofilms (92-94). While PIA cannot be completely disregarded for
its function in S. aureus biofilms, it appears that PIA-independent S. aureus biofilms may
rely more on proteins and eDNA (95-97) than the closely related species
Staphylococcus epidermidis.
Other components to consider as possible constituents of the ECM during early
biofilm development are intracellular components. In support of this, a recent report
demonstrates that S. aureus biofilms appear to recycle cytoplasmic proteins not typically
characterized as biofilm-related proteins such as enolase and GAPDH which are
somehow released into the extracellular milieu to attach to the surface of the cell (98).
Although the mechanisms of how cytoplasmic proteins devoid of a signal peptide can be
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transported into the extracellular milieu still remains unknown, the authors speculate that
the accumulation of these moonlighting proteins in the ECM may be associated with
mechanisms of autolysis-mediated release of eDNA. This may be a likely scenario
considering eDNA release mediated via cell death and lysis by the cidABC and lrgAB
operons and atlA has been shown to play a significant determinant in S. aureus biofilm
structuring (discussed in detail below) (99-104). In conjunction with eDNA release, there
are reports of proteins interacting with the eDNA within the ECM to provide the biofilm
with structural support. Two recent examples include the moonlighting cytoplasmic
proteins, enolase and GAPDH, binding to eDNA under low pH conditions (105) and the
presence of eDNA to initiate PSM-mediated amyloid fiber production (106). In addition,
there is data to suggest that cytoplasmic nucleoid-associated proteins (NAPs), typically
used for chromosomal structuring, may also serve as a biofilm scaffold when released
from the cell by binding eDNA (107). Likewise, other extracellular proteins such as betatoxin (Hlb) (108) and the immunodominant surface antigen B (IsaB) (109) also have
shown the ability to bind eDNA and potentially play a role in biofilm scaffolding.
Detachment/Dispersal Stage
During the last stage of biofilm development, the S. aureus cells switch from a
biofilm state of growth to planktonic cells by detaching from the biofilm and dispersing to
other sites to potentially start the biofilm process over. Normally, this process is thought
to be controlled by the modulation or degradation of the ECM. Indeed, dispersal of S.
aureus biofilms has been shown to be under the control of the Agr, quorum sensing
network (85, 110) which controls several genes associated with ECM modulation. The
first studies examining the contribution of the Agr system in S. aureus biofilm
development demonstrated that agr-deficient strains developed more robust biofilms
when compared to their wild-types counterparts (85) suggesting that the Agr system may
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play a potential role in detachment of biofilms. Yet, it was not until flow-cell studies
evaluating to role of Agr quorum sensing during S. aureus biofilm development that a
more direct role was identified. More specifically, time-lapse microscopy identified that
the P3 promoter was differentially expressed in a subpopulation of cells located primarily
in the tower/microcolony portions of the biofilm. Additionally, P3 expression appeared to
oscillate in waves over time coinciding with detached cells of the biofilm (110). While this
initial report provided support that agr activity plays a role in dispersal of biofilms, the
agr-regulated factors that mediate dispersal still remained unclear. It wasn’t until later in
which two independent studies provided evidence of contrasting modes of agr-mediated
dispersal mechanisms. In one study, it was shown that the Agr system regulates
expression of secreted proteases that degrade proteinaceous components of the ECM in
order to disperse the biofilm. It was also demonstrated that there was a direct correlation
of P3 activation via induction by AIP and dispersal of intact biofilms which they propose
is due to increased protease activity (111). While this provides a connection with
protease activity, Agr is not the only known regulator of the secreted proteases. In fact,
other master regulators such as SarA, SigB, SaeRS, and Rot (33, 112-115) have all
been shown to mediate protease activity and biofilm maturation.
An alternatively proposed agr-dependent dispersal mechanism is the production
of the PSM peptides. These short amphipathic, α-helical peptides have been shown to
be under the regulation of Agr system via direct binding of AgrA to the psm operon
promoters, and under certain growth conditions, have been implicated in dispersing
staphylococcal (116, 117). Indeed, S. aureus isogenic mutants in the either classes of
PSMα or PSMβ or δ-toxin demonstrated more robust biofilm formation (117). Like the
Yarwood et al. study, it was also shown that the induction of the Agr-system and the psm
operon promoters correlates with waves of dispersal during late stages of biofilm
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development (117). It is thought that when PSMs are produced that they act like
surfactants disrupting covalent interactions within the biofilm matrix to mediate dispersal
(27, 76). While the surfactant-like properties of the PSMs may indeed be the major
player in biofilm dispersal, there is also contrasting evidence suggesting that under
certain conditions that aggregation of the PSMs into nonsoluble amyloid-like fibers might
abrogate biofilm dispersal and contribute to the integrity of the biofilm structure (118).
Hence, the production of PSMs solely may not initiate dispersal, but rather the state in
which the PSMs are assembled may contribute directly to the biofilm disassembly.
Additionally, it is also apparent that the presence to of eDNA promotes the formation of
these amyloid-like structures (106) suggesting a necessity for the production and
interplay between ECM components to allow proper biofilm development.
Apparently separate from the Agr-mediated dispersal mechanisms, the
production of two extracellular nucleases also have a function in biofilm detachment.
eDNA is an important component of the ECM, and several studies have demonstrated
that both the secreted nuclease (Nuc) and suface-attached nuclease (Nuc2) degrade
eDNA initiating biofilm dispersal (100, 119-122). However, the studies in this dissertation
demonstrate that nuclease-mediated detachment may be important form proper
maturation under certain conditions, rather than an endpoint like Agr-mediated
processes.
Mechanisms of cell death and lysis
The existence of pronounced death and lysis during bacterial biofilm
development has led to the proposal that these relatively simple organisms have the
capacity to control cell viability in a process analogous to apoptosis in more complex
eukaryotic organisms (123, 124). A key function of these processes, referred to as
bacterial programmed cell death (PCD), is likely to release genomic DNA into the biofilm
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matrix, where it serves as an effective intercellular adherence molecule. The importance
of extracellular DNA (eDNA) as a matrix molecule was originally demonstrated in
Pseudomonas aeruginosa (125) and has since been shown to be important for biofilms
produced by a wide range of bacterial species (99, 100, 125-129). Although some
reports suggest the involvement of bacteriophage in DNA release during biofilm
development (129-132), the presence of distinct regions of cell death and lysis indicates
that this process is highly regulated (100, 126, 129, 133).
Insight into the molecular mechanisms controlling PCD has come from studies of
the S. aureus cidABC and lrgAB operons, which were originally characterized as
mediators of murein hydrolase activity and lysis (134-136). The mode of action of their
gene products has been hypothesized to involve a mechanism analogous to the holin/antiholin-mediated control of host cell lysis during bacteriophage infection (123, 137). A
role for these operons during biofilm development was demonstrated by the
observations that cid and lrg mutations affect biofilm formation, disrupting the normal
architecture that is a characteristic of these multicellular communities (99, 100).
Additionally, it was established that the cid mutant produced biofilm with reduced levels
of matrix-associated eDNA, while the lrg mutant exhibited increased levels of this matrix
component (100). Similar effects on biofilm development were also produced by
Pseudomonas aeruginosa in which homologues of cid and lrg had been disrupted (138).
These results suggest the existence of a careful balance between death effectors and
inhibitors in normal biofilm, not unlike that proposed to control normal tissue
homeostasis in more complex developmental organisms (124). Moreover, they support
the notion that this mechanism is conserved in other bacterial species.
Recent evidence also suggests that Cid-/Lrg-like proteins are conserved much
more broadly than was originally recognized. Recent studies of a putative Arabidopsis
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CidAB/LrgAB homolog, designated AtLrgB, indicated that this gene is an important
regulator of cell death in plants (139, 140). Disruption of the gene encoding AtLrgB
produced plants with interveinal chlorotic and premature necrotic leaves, suggesting the
involvement of this protein in leaf senescence. Furthermore, recent studies (141) also
support the model that the mammalian Bcl-2 family of proteins functions in a manner
analogous to holins and antiholins. Strikingly, these studies demonstrated that the death
effector and inhibitor components of the Bcl-2 protein family can induce cell death and
lysis in Escherichia coli similar to holins and antiholins, respectively. Indeed,
replacement of the normal holin of bacteriophage lambda with derivatives of human Bax
protein resulted in the formation of functional, plaque forming viral particles. These
results suggest that the functions of the Cid and Lrg proteins span at least three
Kingdoms of life.
It is clear that any model of controlled cell death and lysis during biofilm
development must accommodate the observation that only a subpopulation of cells
undergoes this process. Structured biofilms exhibit obvious spatial differences in cell
viability and lysis, including localized dead cell and eDNA staining in towers and more
homogeneous live cell populations in the basal biofilm (100, 126, 129, 133). This has led
us to hypothesize that the differential expression of cell death and lysis within biofilm
subpopulations is dictated by the heterogeneous expression of the cid and lrg operons
within the biofilm (123, 124), possibly as a result of the metabolic heterogeneity
commonly observed in them (142). The combined effects of metabolism are envisioned
to result in an optimal balance of expression that is essential for normal biofilm
development (124). Indeed, expression of the S. aureus cidABC and lrgAB operons has
been shown to be tightly coordinated by regulators that sense and respond to basic
metabolic processes. For example, cidABC expression is induced by the LysR-type
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transcriptional regulator, CidR, under conditions of excess glucose and oxygen (overflow
metabolism) (143-145), while lrgAB expression is stimulated by changes in membrane
potential in a process that is dependent on the two-component regulatory system, LytSR
(146). Although much is known about the regulatory signals important in cidABC and
lrgAB expression, how these signals are integrated during biofilm development remains
unknown.
BioFlux1000 microfluidic technology1
Given the propensity at which staphylococci develop biofilms and cause chronic
infections, assays to aid in the understanding the molecular mechanisms in biofilm
maturation are essential. Above all, biofilm assays designed to evaluate biofilm
development in a real-time manner are of becoming particularly essential. The new gold
standard for assessing developmental processes associated with biofilm formation are
flow-cell systems that allow for the perfusion of media across bacterial cells attached to
a synthetic surface, thus, providing a constant supply of nutrients under the pressure of
a shear force. Today, several commercially available flow-cell systems from companies
such as BioSurface Technologies, Corp., Stovall Life Science, Inc., and Fluxion
Biosciences, Inc. are available for use in biofilm studies. In fact, a variety of flow-cell
systems ranging from single to multi-channel designs are available in either reusable or
disposable forms. While some flow-cell systems allow researchers to test the effects of
various surfaces such as glass slides/coverslips, polycarbonate coupons, and plastic
capillary tubing on biofilm development, others are designed to maximize versatile image
acquisition using a high-throughput plate format. An example of this is the microfluidic
system the BioFlux1000. The BioFlux1000 is comprised of an epifluorescence

Majority of this section has been published in Derek E. Moormeier and Kenneth W.
Bayles. 2014. Methods Mol Biol.
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microscope equipped with an automated temperature-controlled stage, a pneumatic
compressor, a high-resolution camera, and specialized 24-well or 48-well plates
equipped with microfluidic channels that connect two adjacent wells, one for sterile
media and the other for effluent (Figure 1-1) (147).

The microfluidic channels are

seeded with bacteria and the sterile media is pneumatically perfused through the
channels, resulting in biofilm growth. To assess biofilm development in each channel
(up to 8 or 24 biofilms, depending on the plate being used), sequential images are
automatically acquired using the high-resolution camera and compiled using BioFlux
Montage image analysis software. Collectively, the automated image acquisition and the
simultaneous growth of multiple biofilms enable an unprecedented comparison of biofilm
development by bacterial strains containing different mutations. Additionally, the use of
metabolic stains and/or fluorescent reporters allows for the localization of spatial and
temporal patterns of metabolic activity and gene expression within the developing biofilm
architecture (147, 148).

Although the evaluation of the biofilm images is primarily

qualitative, the BioFlux data analysis software contains some functions that enable areas
of the two-dimensional images of light and/or fluorescence intensity to be quantified
(147). In these studies, we took advantage of the BioFlux1000 capabilities to maximize
evaluation of S. aureus biofilm in real time.
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Figure 1-1 BioFlux1000 Interface, Gasket, Tubing, Stage, and 48-well plate setup
The BioFlux Interface locks the BioFlux plate to the heated stage and is connected to the
BioFlux Controller via small tubing. The tubing allows media to be pneumatically pumped
into the microfluidic channels of the BioFlux plate. It is important during every attachment
of the BioFlux Interface to the BioFlux Plate to apply as little pressure as possible to the
top of the Interface to prevent the plate from cracking.
Figure modified from Derek E. Moormeier and Kenneth Bayles. 2013. Methods Mol Biol.
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CHAPTER II:
MATERIALS AND METHODS
Table 1. Bacterial strains and plasmids used in these studies
Bacterial Strains
Escherichia coli
DH5α

Description

Reference

Host strain for construction of recombinant plasmids

(149)

S. aureus
RN4220
UAMS-1
UAMS-1471
UAMS-155
UAMS-1 hsdRKB999
KB1090
*KB8037
KB8000
KB8001
USA300 LAC JE2
JE2 agrA:: ΦΝΣ
JE2 nuc::ΦΝΣ
JE2 atlA::ΦΝΣ
AH1263
AH1558
AH1919
AH2216
**CFS93
**AH3499
AH3500

Highly transformable strain; restriction-deficient
Wild-type osteomyelitis clinical isolate
UAMS-1 ∆nuc
UAMS-1 agr::tet
UAMS-1 restriction-deficient
UAMS-1 lytS::ermC
UAMS-1 cidR::ermC
UAMS-1 icaA:: ΦΝΣ
UAMS-1 ∆ackA::ermB, Ermr
UAMS-1 ∆pta
USA300 LAC derivative
bursa aurealis agrA mutation in JE2
bursa aurealis nuc mutation in JE2
bursa aurealis atlA mutation in JE2
USA300 CA-MRSA Erms LAC derivative
AH1263 saeQRS::spc
AH1263 Δaur ΔsspAB ΔscpA spl::erm (protease KO)
AH1263 ∆saePQRS
AH1263 ∆saeP
AH1263 ∆saeQ
AH1263 ∆saeS

(150)
(151)
(112)
(152)
(153)
(146)
(145)
This study
(154)
(154)
(155)
(155)
(155)
(155)
(97)
(48)
(156)
(157)
Horswill lab
Horswill lab
(157)

Plasmids
pCR2.1
pJB38
pBK123
pEM64
pEM80
pEM81
pEM87
pCM11
pKH4
pDM4

E. coli PCR cloning vector
Temperature sensitive allelic exchange plasmid
Shuttle vector, pCN51ΔEM::CAT; CmR
pBK123 derivative containing Cd-inducible GFPaav
lrgAB promoter::sGFP, CmR
cidABC promoter::sGFP, CmR
ldh1 promoter::sGFP, CmR
Shuttle vector encoding sGFP
Agr P3 promoter::sGFP
lrgAB promoter::sDsRed, cidABC promoter::sGFP

Invitrogen
(158)
(159)
This study
This study
This study
This study
(160)
(161)
This study
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pSC14
sarA promoter::sDsRed, cidABC promoter::sGFP
pDM17
sarA promoter::sDsRed, nuc promoter::sGFP
pDM19
coa promoter::sDsRed, nuc promoter::sGFP
pCM20
nuc promoter::sGFP
pCM27
hla promoter::sGFP
pCM11hlgA
hlgA promoter::sGFP
pCM11P1sae
P1sae promoter::sGFP
pRMC2
anhydrotetracycline inducible plasmid
pRMC2-nuc
anhydrotetracycline inducible plasmid containing nuc
**pJB38-∆saeP
AH1263 ∆saeP allelic exchange plasmid
**pJB38-∆saeQ
AH1263 ∆saeQ allelic exchange plasmid
*Strain constructed by Jennifer L. Endres from Bayles laboratory, but
been published.

Thomas lab

This study
This study
(119)
(157)
(157)
(157)
(112)
(119)
Horswill lab
Horswill lab
has not yet

**Strains and plasmids constructed in Dr. Alexander Horswill laboratory by Dr.
Caralyn Flack, but have not yet been published.
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Table 2. Oligonucleotides
Primer Name
cidA-pro-F

Sequence
5’-CCCGCATGCAGCAAATTATCAATGATGAAGTAGATA-3’

cidA-pro-R

5’-CCCGGATCCCGCCATCCCTTTCTAAATAC-3’

lrgA-pro-F

5’-CCCGCATGCCGATAAAATTCACATGTTAAAGC-3’

lrgA-pro-R

5’-CCCGGATCCCGTTTGATTTAACTAAAGTATAGATGG-3’

ldh1-pro-F

5’-CCCGCATGCATGGCTTTTAATAAATTTTC-3’

ldh1-pro-R

5’-CCCGGATCCTACAAAAACTCCCTTATGAT-3’

cidA-rt-F

5’-GGGTAGAAGACGGTGCAAAC-3’

cidA-rt-R

5’-TTTAGCGTAATTTCGGAAGCA-3’

lrgA-rt-F

5’-GCATCAAAACCAGCACACTTT-3’

lrgA-rt-R

5’-TGATGCAGGCATAGGAATTG-3’

sigA-rt-F

5’-AACTGAATCCAAGTCATCTTAGTC-3’

sigA-rt-R

5’-TCATCACCTTGTTCAATACGTTTG-3’

DsRed-F

5’CAGAGTCGACTGATTAACTTTATAAGGAGGAAATACATATGGAC
AACACCGAGG-3’

DsRed-R

5’-ACATGCATGCTACAGGAACAGGTGGTGGCGG-3’

sGFP-F

5’CACGAATTCTGATTAACTTTATAAGGAGGAAAAACATATGCCCG
GGAGCAAAGGAG-3’

sGFP-R

5’-CCTGGCGCGCCTTCTTATTTGTAGAGCTCATCCATGCC-3

lrgA-R

5’-GCTGGATCCACGTTTGATTTAACTAAAGTATAGATGGCTCAC-3’

cidA-R

5’GCCGGAATTCTAAATACGTCTAAATTGTTACAATAACTATTATAA
AGATGGCG-3’

cidABC-lrgABF
lrgAB-cidABCF
sDsRed-F

5’GTTTCCAGTCCATTCAAGCGTTCCGCACATGACCAATACGCAGT
ACAG-3’
5’CTGTACTGCGTATTGGTCATGTGCGGAACGCTTGAATGGACTG
GAAAC-3’
5’-AGCGGATCCAGATAATCTATAAAAGGAGG-3’

sDsRed-R

5’-TCTTGCATGCTTATAAAAACAAATGATGACGAC-3’

MJT240

5’-GTTGTTGAATTCACCTGTATACATTACAGACC-3'

CEF169

5'CAGAAATTGAGTACTAGATCTGTATTCATGCTAACTCCTCATTTC
- 3'

CEF170

5’GAATACAGATCTAGTACTCAATTTCTGAGTTAAACTTTTATTTAC
AAC- 3'

CEF171

5’- GTTGTTGGTACCAAGAAACTAGCAGCATATGC - 3'

CEF172

5' - GTTGTTGAATTCCCTAACAGGTACATTCAGTTC -3'
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CEF173

5'GCGAGTACTAGATCTCATTCTTTCTATTTATTGTGTGTAATTTAT
AT - 3'

CEF174

5' - AGAATGAGATCTAGTACTCGCAAATATAGTTGCACATAC - 3'

CEF175

5’- GTTGTTGGTACCGATGGTATATGTTGTAAAGCTCTC - 3'

icaA-F

5’-CATTGAACAAGAAGCCTGAC-3’

icaA-R

5’-CTGCTGTATTATCTGAACTTCC-3’

Type III-F

5’-CATCGAATGCGTTAAAGGTTAATTATGAGC-3’

Type III-R

5’-CACTATCGTCTCCTGTTAAAGCAACAC-3’

cna-F

5’-AGTGACATGGTCTAATCTTCCGG-3’

cna-R

5’-TCCACTTTTGATGGCTTATCTGG-3’

Dual-coa-F

5’-GCCGCTGCAGGTTTCGCTTTAGTCATTTGAT-3’

Dual-coa-R

5’-GCCGGGATCCATGTAATTGCCCAATCTACAT-3’

Dual-nuc-F

5’-GCCCGCTGCAGGTAAATTATAAGTTATACATCTCG-3’

Dual-nucR

5’GCCGGAATTCCTTTTTAGTTAATTTTAATATTAAACG-3’
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Bacterial strains and growth conditions
Staphylococcus aureus and Escherichia coli strains used in these studies are
described in Table 1. All strains of E. coli were grown in Luria-Bertani broth (LB) or LB
containing 1.5% agar. All S. aureus strains were grown in tryptic soy broth (TSB) (EMD
Biosciences, Gibbstown, NJ) or on TSB containing 1.5% agar. All experiments were
started from fresh overnight TSB cultures grown at 37°C with shaking at 250 rpm. To
determine expression of fluorescent reporters fusions in Chapter III by planktonic aerobic
growth, cultures were generated by inoculation of overnight cultures into TSB medium
with or without glucose to an OD600 of 0.1 and incubation with shaking at 250 rpm at
37˚C using a 10:1 flask to volume ratio. Hypoxic growth was achieved by growing the
cells statically at 37˚C in a covered flask at a 5:3 flask to volume ratio. Dissolved oxygen
levels were measured using a portable dissolved oxygen meter (Accumet) per the
manufacturer’s instructions. As needed, chloramphenicol (5 µg ml-1), erythromycin (5 µg
ml-1), tetracycline (5 µg ml-1), ampicillin (100 µg ml -1), and spectinomycin (1000 µg ml-1)
were added to the growth medium.

Planktonic growth analysis of S. aureus sae mutations
To determine any growth defects of sae mutations during planktonic aerobic
growth described in Chapter III, cultures were generated by adjusting overnight cultures
to an OD600 0.06 in TSB containing 0.25% glucose and then grown for 24 hours with
shaking at 250 rpm at 37°C using a 10:1 flask to volume ratio. Subsequently,
supernatants were taken at 0, 3, 6, 9, 12 and 24 hours and the OD600 were measured
and plotted over time.
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Determination of exogenous DNA growth and nuc expression on planktonically
grown AH1263 and sae mutant cells
At a flask ratio of 10:1, S. aureus overnights were adjusted to OD600 0.06 in 25 ml
of TSB containing 0.25% glucose buffered in 50 mM 3-(N-morpholino)propanesulfonic
acid (MOPS) at a pH 7.4 with or without different percentages of exogenous salmon
sperm DNA. Cultures were agitated at 250 rpm and grown for up to 24 hrs. To determine
the effect on growth and relative fluorescence, OD600 supernatants were read first. Next,
another supernatant of cells were washed once in 1x PBS and 200 µl were pipetted into
a 96-well flat-bottom, black polystyrene plate (COSTAR 3916). Fluorescence was
quantified using a Tecan Infinite 200 spectrofluorometer with an excitation wavelength of
490 nm and emission wavelength of 525 nm. Relative fluorescence was determined by
normalizing the quantified fluorescence per OD600 and plotted using GraphPad Prism. To
determine the effect of exogenous DNA on solely growth, the OD600 were plotted over
time using GraphPad Prism.

Generation of transcriptional reporter fusions
The S. aureus cidABC, lrgAB, and ldh1 promoter regions were PCR-amplified
using oligonucleotide primers flanking these sequences and Thermolace high fidelity
DNA polymerase (Invitrogen, Carlsbad, CA). Specifically, a 689 nt DNA fragment
spanning the promoter region of cidABC (PcidABC), and a 500 nt DNA fragment spanning
the promoter regions of lrgAB (PlrgAB) and ldh1 (Pldh1), were amplified using the cidA-pro,
lrgA-pro, and ldh1-pro primer sets, respectively, listed in Table 2. Each promoter
fragment was ligated into pCR2.1 using the Invitrogen TA cloning kit (Carlsbad, CA) and
the recombinant plasmids were transformed into E. coli DH5α cells (Table 1). After
confirming the absence of mutations by nucleotide sequencing, the promoter fragments
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were excised by digestion with the restriction endonucleases, SphI and BamHI, and
used to replace the cadmium-inducible promoter in front of the gene encoding the short
half-life GFPaav in the plasmid, pEM64. Due to the weak fluorescence of GFPaav, the
GFPaav gene was replaced with the gene encoding superfolder GFP (sGFP) from
pCM11 (Table 1).
A dual reporter plasmid (designated pDM4) containing divergently transcribed
cidABC and lrgAB promoter regions fused to genes encoding green and red fluorescent
proteins, respectively, was constructed as follows. Primers DsRed-f and DsRed-r (Table
2) were used to amplify the gene encoding DsRed.T3(DNT) fluorescent protein (162).
The 717 bp DsRed.T3(DNT) PCR product was ligated into the SalI-SphI sites of the
shuttle vector, pBK123 (Table 1), producing pDM1. Using primers lrgA-r, cidA-r, cidABClrgAB-f, and lrgAB-cidABC-f (Table 2), the promoter regions spanning 833 bp and 602
bp upstream of cidABC and lrgAB, respectively, were amplified from the S. aureus
UAMS-1 chromosome and combined using a SOEing (splicing by overlap extension)
technique (163) resulting in a 1,441 bp DNA fragment containing the cid and lrg
promoters in a divergent orientation. After confirmation of this fragment by nucleotide
sequencing, it was ligated into the EcoRI and BamHI sites of pDM1 to generate pDM2.
Next, a 768 bp DNA fragment encoding sGFP from pEM80 was amplified using the
primers, sGFP-r and sGFP-f (Table 2), and then ligated into the EcoRI and AscI sites of
pDM2, generating pDM3. Finally, due to the weak expression of the gene encoding
DsRed.T3(DNT), the coding region was optimized for codon usage in S. aureus, and
synthesized by Invitrogen-GeneArt (Carlsbad, CA). This gene was then used to replace
the un-optimized DsRed.T3 (DNT) gene in pDM3, resulting in the plasmid, pDM4.
The generation of pDM19 was performed as follows. First, pDM17 was
generated by amplifying the promoter region 319 bp upstream of nuc transcription start
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site from the AH1263 chromosome using the Dual-nuc-F/Dual-nuc-R primer pair (Table
2). After amplification of the nuc promoter region, it was digested with EcoRI and PstI
and ligated into pSC14, resulting in the dual reporter PsarA::sDsRed and Pnuc::sgfp
plasmid pDM17 (Table 1). Upon confirmation, 455 of the coa promoter region was
ampilified from the AH1263 chromosome using the Dual-coa-F/Dual-coa-R primer pair
(Table 2). This 445 promoter region was then digested with PstI and BamHI and ligated
into pDM17. The resulting plasmid, Pcoa::sDsRed and Pnuc::sgfp dual reporter plasmid,
was named pDM19 (Table 1).

Generation of icaA::ΦΝΣ mutation in UAMS-1 S. aureus2
The UAMS-1 icaA::φΝΣ mutant was generated via transduction using φ11
propogated in the Nebraska Transposon Mutant Library (NTML) mutant, NE37 (155).
Due to issues moving the icaA::φΝΣ transposon into wild-type UAMS-1, initially, the
mutation was transduced into a UAMS-1 restriction deficient isolate (153) as described
below. Resulting colonies were screened for transposon insertion utilizing primer pair,
icaA-F and icaA-R. The transduction process procedure was repeated to move the
mutation from the UAMS-1 restriction deficient strain into the wild-type UAMS-1
background. These transductants were confirmed to be UAMS-1 background by PCR
amplification of the UAMS-1-specific cna gene with the primer pair cna-f and cna-R and
primers specific for the type III restriction system, Type III-F and Type III-R. The resulting
strain was named KB8037.

The construction of this strain was performed by Jennifer Endres in the Bayles
laboratory, but has not yet been published.
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Construction of ∆saeP and ∆saeQ mutations in AH1263 S. aureus3
To construct the ∆saeP mutant in AH1263, two-step overlap PCR was used to
create pJB38-∆saeP. 600 bp regions directly upstream and downstream of saeP were
amplified from AH1263 genomic DNA with primer pairs MJT240/CEF169 or
CEF170/CEF171 respectively, where CEF169 and CEF 170 contained complementary
overlap regions (Table 2). The upstream and downstream PCR products were purified
by agarose gel electrophoresis. 2ml of each purified product were mixed and used as
the template for the second round of PCR with primer pair MJT240/CEF171. The
resulting 1.2kb PCR product was purified, digested with EcoRI and KpnI and ligated into
similarly digested pJB38 (158). The resulting plasmid was used to construct a
markerless ∆saeP strain in the AH1263 background as previously described (158) and
was named CEF93 (Table 1).
Similarly, to construct the ∆saeQ mutant in AH1263, two-step overlap PCR was
used to create pJB38-∆saeQ 600 bp region directly upstream and 900 bp region
downstream of saeQ were amplified from AH1263 genomic DNA with primer pairs
CEF172/CEF173 or CEF174/CEF175 respectively, where CEF172 and CEF175
contained complementary overlap regions (Table 2). The upstream and downstream
PCR products were purified by agarose gel electrophoresis. 2ml of each purified product
were mixed and used as the template for the second round of PCR with primer pair
CEF172/CEF175. The resulting 1.2kb PCR product was purified, digested with EcoRI
and KpnI and ligated into similarly digested pJB38 (158). The resulting plasmid was
used to construct a markerless ∆saeQ strain in the AH1263 background as previously
described and was named AH3499 (Table 1).
The construction of these strains was performed by Dr. Caralyn Flack in the
laboratory of Dr. Alexander Horswill (University of Iowa), but has not yet been
published.
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Movement of plasmids into S. aureus strains
All plasmids were purified from the S. aureus strains or E. coli strains using the
Wizard Plus SV Minipreps DNA purification system (Promega Corporation) according to
manufacturer’s instructions, and then electroporated into the highly transformable,
restriction-deficient S. aureus strain RN4220 (Table 1). Transduction of the plasmids
(Table1) into UAMS-1, JE2, or AH1263 (or mutant derivatives) strains was performed
using φ11 phage propagated on the plasmid-containing RN4220 strain as previously
described (164).

Confocal microscopy imaging of planktonic expressing reporter S. aureus strains
Planktonic S. aureus cells expressing fluorescent reporter genes were imaged by
CLSM as follows. Overnight cultures were diluted to an OD600 of 0.1 into fresh medium
and incubated under aerobic and hypoxic conditions as described above. Samples of the
cultures were harvested and pelleted by centrifugation at 14,000 × rpm for 3 min. The
pellets were resuspended in 0.85% NaCl to an approximate OD600 of 5.0, and 2.5 µl of
each preparation was placed on a microscope slide and covered with a coverslip. An
inverted Zeiss 510 Meta CLSM fitted with a Plan-Apochromat 63×/1.40 Oil DIC M27
objective set to a 3.0× digital zoom was used to image the cells. An argon 488 nm laser
was used to excite any GFP present in the cells and the emissions were collected using
a 505-550 band pass filter. Images collected were processed using the Imaris 7.0.0
software suite (Bitplane, Saint Paul, MN).
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RNA quantification
Total S. aureus RNA was isolated as previously described (146) with minor
modifications as follows. Briefly, S. aureus cells were harvested by centrifugation at
4,100 r.p.m. in a Sorvall Legend table-top centrifuge (Newtown, CT) and the resulting
pellets were resuspended in 500 μl of TSB. Then 1.0 ml of RNAprotect Bacteria Reagent
(Qiagen, Valencia, CA) was added, samples were vortexed vigorously for 30 sec and
incubated at room temp for 15 min. Cells were then pelleted by centrifugation at 5,000 x
g for 10 min in a Microfuge 18 centrifuge (Beckman-Coulter, Brea, CA); supernatants
were removed and pellets were stored at -80˚C. Once all samples had been collected,
the cells were thawed for 10 min, resuspended in 900 µl of RLT buffer, and RNA was
isolated using an RNeasy Mini RNA Purification Kit (Qiagen, Valencia, CA) as described
previously (146).
Quantitative real-time PCR was performed using cidA-, lrgA-, and sigA-specific
primers listed in Table 2. Briefly, 500 ng of total RNA was converted to cDNA using the
Quantitect Reverse Transcription Kit from Qiagen (Valencia, CA). The samples were
then diluted 1:50 and the cidA, lrgA, and sigA cDNA products were amplified using 5.0
µM cidA-rt, lrgA-rt, and sigA-rt primers (Table 2), respectively, with the LightCycler DNA
Master SYBR Green I kit (Roche Applied Science, Indianapolis, IN), following the
manufacturer’s instructions. Fold changes in cidA and lrgA transcript levels were
calculated using the comparative CT method (165), normalizing to the amount of sigA
transcripts present in the RNA samples. Results were recorded in triplicate,
representative of three independent experiments.
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Fluorescence-activated cell sorting flow cytometry of cells grown planktonically
To count the number of cells expressing nuc in planktonic cells cultures, S.
aureus strains grown overnight were adjusted to an OD600 of 0.06 in 12.5 ml of TSB
containing 0.25% glucose and grown for 4 hours with shaking at 250 rpm at 37°C using
a 10:1 flask to volume ratio. After 4 hours of growth, 1000 µl of cells were washed with
1x phosphate buffer saline (PBS) and then 200 µl of washed cells were pipetted into a
clear 96-well plate and analyzed on a BD LSRII flow cytometer (Beckton and Dickinson,
San Jose, California). A total of 10,000 events from each cell culture sample were
analyzed at a flow rate of 1000 cell per second. Bacteria were distinguished from
background using forward and side scatter light using wild-type cells without a
fluorescent reporter plasmid as a negative control. To enumerate sGFP positive cells,
samples were excited at 488 nm using an argon laser and detected using a 530+30 nm
(with a 505 nm long-pass filter). The raw data were then analyzed and plotted using
FlowJo data analysis software (FlowJo, LLC, Ashland, OR).

Biofilm assays
BioFlux1000 biofilm assays to evaluate gene expression and biofilm morphologies
To monitor gene expression and biofilm morphologies, S. aureus biofilm
development was assessed using a BioFlux1000 microfluidic system (Fluxion
Biosciences Inc., San Francisco, CA) as described previously (148). Using BioFlux1000
48-well plates, the biofilm growth channels were primed by adding 200 µl of TSB to the
output wells and initiating a reverse flow for 5 min at 5.0 dyn/cm2. To seed the channels
with bacteria, excess TSB in the output wells was replaced with 200 µl of fresh overnight
S. aureus cells diluted to an OD600 of 0.8 and pumped into the channels at 2.0 dyn/cm2
for 5 sec. Cells were then allowed to attach to the surface of the plate for 1 hour at 37°C.
Remaining inocula was aspirated from the output well and 1.3 ml of 50% TSB was

31
added to the input wells and pumped at 0.6 dyn/cm2 for 18 hours (Figure 2-2 depicts
macroscopic view of serpentine channels, output and input wells, and the center viewing
area). Brightfield and epifluorescence images were acquired in 5-min intervals for a total
of 217 time points. All epifluorescence images observing GFP and/or sDsRED
expression

were

acquired

using

a

fluorescein

isothiocyanate

(FITC)

and

Tetramethylrhodamine (TRITC) filters, respectively, and kept at constant acquisition
settings (FITC; Gain: 20, Exposure: 500 ms and TRITC; Gain: 10, Exposure: 600ms).
For a more detailed protocol of utilizing the BioFlux1000 to evaluate staphylococcal
biofilm development, refer to reference (166).
To ensure nuclease was actively being made using the inducible aTet plasmid
system (pRMC2 and pRMC2-nuc) under non-inducing conditions, wild-type and ∆nuc
mutant strains containing pRMC2 or pRMC2-nuc supernatants from effluents of 3-h
biofilms grown in the BioFlux without aTet were incubated with S. aureus genomic DNA
overnight and separated in a 1% agarose gel.

Determination of adding proteinase K, DNaseI, or PAS to biofilms grown in
BioFlux1000
To determine the effects of proteinase K (Invitrogen Inc.), DNase I (Fermentas
Inc.), or lysis-inhibitor polyanethole sulfonate (PAS) on biofilm development in the
BioFlux1000, channel priming and cell seeding were performed as described above and
1 ml of 50% TSB or 1 ml of 50% TSB supplemented with either 100 µg ml-1 of proteinase
K, 0.5 units ml-1 of DNase I, or 50 µg/ml of PAS was pumped at 0.6 dyn/cm2 for eight
hours. Where indicated, flow was stopped intermittently and 1 ml of 50% TSB was
replaced with 1 ml of 50% TSB supplemented with proteinase K or DNase I. After
restarting the flow, brightfield images were acquired in two-hour intervals.
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Figure 2-1 Macroscopic view of a 48-well BioFlux plate
Macroscopic view of input and output wells of a 48-well BioFlux plate with media in the
center of wells. Circle in the center of wells is the viewing window of the microfluidic
channels. To prime channels, 200 μl of TSB is pumped for 5 min from output to input
wells. After excess TSB is aspirated from output, 200 μl of adjusted inoculums are
seeded into the channels by pumping for 5 s from output to input wells. After 1 h
incubation, biofilms are grown in 50 % TSB pumped from input to output wells for 18 h at
0.6 dyn/cm 2 (64 μl/h).
Figure modified from Derek E. Moormeier and Kenneth Bayles. 2013. Methods Mol Biol
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Determination of adding exogenous DNA to biofilms grown in BioFlux1000
To determine the effects of adding exogenous DNA to S. aureus biofilms grown
in BioFlux1000, an overnight culture of S. aureus wild-type UAMS-1 strain was adjusted
to an OD600 of 0.8 in TSB containing 0.25% glucose and then seeded and into
microchannels of BioFlux1000 plate as described above and allowed to adhere for 1
hour at 37°C. Subsequently, an arbitrary amount of lyophilized salmon sperm DNA (1 µg
ml-1) resuspended in 50% TSB buffered in MOPS at a pH 7.4 or 50% TSB buffered in
MOPS at a 7.4 were perfused over attached cells for 18 hours at a shear stress of 0.6
dyn/cm2 and images were acquired in 5 minute intervals. The 6 hour time point of biofilm
coverage was quantified as described below and plotted using GraphPad Prism.

Quantification of acquired BioFlux biofilm images
Using BioFlux Montage software (Fluxion Biosciences Inc.), representative
brightfield and epifluorescence images were selected and adjusted to similar brightness
and calibrated to 0.323445 µm/pixel. For brightfield images, a threshold was set using
the Threshold Tool and Slider tool to include all dark objects (biofilm cells) within each
image. The total percent area of coverage of the dark objects was designated as percent
biofilm coverage and plotted over time. For epifluorescence images, a threshold was set
similar to that described above to cover all light objects (fluorescent cells) in each image.
The total percent area of coverage was designated percent fluorescence coverage and
plotted over time. All time points were plotted in either one hour or 15-min intervals using
GraphPad Prism version 5.0 for Windows (GraphPad Software, La Jolla, CA).
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Isolation of eDNA from BioFlux biofilms
S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) biofilms were
grown with or without active DNase I (heat-inactivated 10 min at 95°C) for 4 hours in the
BioFlux system in four identical channels as described above. In the output wells, 200 µl
of 50 mM TES buffer (TRIS-HCl; pH 8.0, 10 mM EDTA, and 500 mM NaCl) containing
10 µg ml-1 chloramphenicol and 50 µg ml-1 proteinase K were added to inhibit cell growth
in the effluent. After 4 hours of biofilm growth, excess media and effluent were removed
from the input and output wells, and the output wells were wiped clean with sterile cotton
tipped applicators. To extract biofilms from channels, 400 µl of 50 mM TES buffer
containing 100 µg ml-1 proteinase K was added to the output wells and then pumped into
the input wells for 10 minutes at 5.0 dyn/cm2 and 10 minutes at 20.0 dyn/cm2. After
ensuring the biofilms had been completely removed from the channels, 350 µl of the flow
through from the four replicate channels were pooled into pre-chilled tubes, centrifuged
for 5 min at 14,000 rpm, and 1 ml of the supernatant was transferred to new tubes.
Excess biofilm supernatants were discarded and pellets were resuspended in 1 ml of
water and kept on ice until OD600 was determined. The eDNA from supernatants was
extracted once with 1 ml of phenol:chloroform:isoamyl alcohol (25:24:1) and once with
900 µl of chloroform:isoamyl alcohol (24:1). To precipitate the eDNA, 500 µl of the
aqueous phase was mixed with 50 µl of 3M potassium acetate (pH 5.0) and 1.5 ml of
ice-cold 100% ethanol and then stored at -20°C overnight. The following day the
precipitated DNA was collected by centrifugation (15,000 × g) for 20 min at 4°C, washed
with ice-cold 75% (v/v) ethanol, air-dried at room temperature, and dissolved in 200 µl of
TE buffer. To quantify the amount of eDNA present, qRT-PCR was performed on each
sample in a LightCycler DNA Master SYBR Green I (Roche) using gyrase primer sets as
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previously described (99), and the eDNA concentrations (ng µl-1) were normalized to
total OD600 in 1 ml of water.

Static biofilm assays
To analyze expression in a static biofilm, overnight cultures of each strain were
grown and diluted to an OD600 of 0.05 in TSB+0.5% glucose with 1.0 µM Toto-3.
Subsequently, 400 µl of each inoculum was placed in one well of an 8-chamber Lab-Tek
Chambered #1.0 Borosilicate Coverglass system (Nunc, Rochester, NY). Biofilms were
grown for 6 hr at which point they were imaged using an inverted Zeiss 510 Meta
Confocal Laser Scanning Microscope (CLSM) with an EC Plan-Neofluar 40x/1.30 na Oil
DIC M27 objective. For each sample several z-stack images were acquired using 488
nm excitation of GFP with 505-550 nm bandpass filter detection, as well as the
acquisition of DIC images. Moreover, 3D reconstructions of the static biofilm images
were completed using the Imaris 7.0.0 software suite (Bitplane, Saint Paul, MN).

Statistical analysis
Differences in eDNA present within the biofilms produced by different strains and
under different experimental conditions were analyzed by performing a one-way ANOVA
test with a Tukey post-test using GraphPad Prism (GraphPad Software, La Jolla, CA).
Data for RNA quantification were analyzed using the Wilcoxon rank-sum test for nonparametric data using GraphPad Prism (GraphPad Software, La Jolla, CA).
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CHAPTER III:4
The Control of Sae-Dependent Nuclease-Mediated Exodus during Early
Staphylococcus aureus Biofilm Development

INTRODUCTION
Biofilms are multicellular communities of bacteria aggregated by a self-produced
extracellular matrix (ECM) comprised of proteins, carbohydrates, and extracellular DNA
(eDNA) (76). In pathogenic bacteria, such as Staphylococcus aureus, the formation of
biofilms within host tissues and on implanted medical devices leads to chronic infections
due to their recalcitrance to antimicrobial therapies and host immune responses (167).
Indeed, S. aureus is a leading cause of a variety of diseases ranging from skin and soft
tissue infections, to more serious illnesses including endocarditis, necrotizing
pneumonia, and osteomyelitis (63, 168, 169), and its ability to form biofilms is an
important determinant of virulence in many of these infections (67).
S. aureus biofilm development has previously been described to occur in three
successive steps: 1) attachment, 2) accumulation/maturation, and 3)
detachment/dispersal (76). The initial attachment step has been shown to involve
different surface factors including teichoic acids (88), potentially through surface charge
interactions, and several different surface-associated proteins that allow the cells to
adhere to either polymeric surfaces or host matrix components (170, 171). As the biofilm
matures, synthesis of the ECM components allows the cells to mature into threedimensional structures (100, 148). Production of the self-produced proteases (33),

The majority of the work in CHAPTER III has been published in Moormeier DE,
Bose JL, Horswill AH, and Bayles KW. 2014. mBio.
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phenol-soluble modulins (PSMs) (117), and nucleases (100, 119) mediate ECM
disruption and the switch from the biofilm lifestyle to planktonic growth. Indeed, adding
exogenous enzymes or peptides targeting various ECM components, including DNase I
(eDNA), proteinase K (proteins), synthetic PSMs (proteins), and dispersin B
(polysaccharide intercellular adhesion [PIA]) have been shown to cause biofilm
disassembly (100, 111, 117, 172).
In the studies described in this chapter, we examined the early stages of biofilm
development and assessed the matrix composition as the biofilm matured.
Unexpectedly, we identified a distinct transition in matrix composition immediately prior
to a previously unrecognized exodus of a subpopulation of the biofilm, which was
initiated prior to the development of tower structures. In addition, we demonstrated that
exodus was dependent on the coordinated, stochastic expression of the gene encoding
the secreted staphylococcal nuclease regulated by Sae two-component system.
Likewise, we also showed that the coordinated stochastic expression is not only limited
to nuclease, but other Sae-regulated factors as well. Together, these findings suggest
the existence of a complex regulatory strategy that controls matrix composition during
the early stages of biofilm development, and provide novel insight into a nucleasemediated exodus of biofilm cells and the regulation of Sae-controlled factors.

RESULTS
Defining the early stages of S. aureus biofilm development
Investigation of S. aureus UAMS-1 biofilm development using a BioFlux
microfluidics system revealed that primary attachment of the S. aureus cells is followed
by rapid multiplication into a confluent “lawn” (Figure 3-1A). At about the 6-hour time
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point, an apparent exodus in a subpopulation of the biofilm was observed, followed by
distinct foci of robust biofilm growth, resulting in tower formation.
To further study these early events in biofilm development, we established a
method to quantify the amount of biofilm coverage occurring over time (Figure 3-1B). To
accomplish this, we set a threshold for dark objects (biofilm cells) within each brightfield
image and measured the percent of the area that these objects covered. The data was
then plotted as percent biofilm coverage versus time. As seen in Figure 3-1B, after the
initial attachment of cells (0 h), there was a gradual increase in the biofilm coverage
observed until about six hours, at which time the population began to contract until about
11 hours. It was during this exodus stage (at approximately 8 h) that we observed the
initial signs of tower development, which proceeded until the termination of the
experiment at 18 hours. To delineate between previously used terminologies of biofilm
formation, the terms, “multiplication” and “exodus”, were chosen to describe these
previously uncharacterized stages of biofilm development (Figure 3-1).

Protein-dependent attachment and multiplication
To characterize the early stages of biofilm development, the contributions of
different ECM components to S. aureus biofilm attachment and multiplication were
examined using the BioFlux system. Unlike other S. aureus strains that produce biofilms
with a PIA-based matrix (92, 95), biofilms produced by both S. aureus UAMS-1 and
USA300 LAC strains have been reported to be PIA-independent (113, 173). In
agreement with this, we observed no difference in early biofilm formation with UAMS-1
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Figure 3-1 Early stages of S. aureus biofilm development
S. aureus UAMS-1 (wild-type) biofilms were grown in a BioFlux microfluidics system,
and bright-field images were captured throughout an 18-h time course experiment. (A)
Representative images at the indicated time points of a typical UAMS-1 S. aureus biofilm
depicting four stages of development: attachment (stage 1), multiplication (stage 2),
exodus (stage 3), and biofilm maturation (stage 4). Attachment of cells to the glass
bottom plate is quickly followed by the multiplication of the cell population into a
confluent “lawn.” An exodus event after multiplication is followed by robust tower
formation. Scale bar, 50 µm. (B) Quantification of typical S. aureus biofilm development
presented as a percentage of biofilm coverage plotted versus time. Labels indicate the
duration during which each biofilm stage is occurring.
Figure modified from Moormeier et al. 2014. mBio.
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or JE2 (a USA300 LAC derivative) (Figure 3-2) mutants in which the genes encoding the
PIA biosynthesis machinery have been disrupted.
In previous studies, we reported that eDNA is an important matrix component in
S. aureus biofilm development and that modulation of the eDNA matrix has a dramatic
effect on biofilm maturation (99, 100, 119, 174), including during the initial stages of
development in a static assay (22). To gain a better understanding of the contribution of
eDNA during early biofilm development under the flow cell conditions used in the current
study, we added exogenous DNase I (0.5 Units ml-1) at various time points (2-h intervals)
during the biofilm attachment and multiplication phases. Similar to a recent study
demonstrating DNase I insensitivity during early biofilm development (175), the addition
of DNase I had no effect on the biofilm through eight hours of growth (Figure 3-3A),
suggesting that the initial attachment and multiplication stages lack eDNA under these
conditions or that the eDNA present in the matrix during this time is insensitive to DNase
I treatment.
S. aureus produces a number of surface-associated and secreted proteins
important for adherence. Considering the findings that the attachment and multiplication
stages are DNase I insensitive (Figure 3-2A), we hypothesized that proteins may play a
critical role in these early biofilm formation events. In agreement with this, the
staphopain proteases have recently been shown to modulate S. aureus biofilm integrity
(33). To test the role of proteins, we performed a similar experiment as above except
adding proteinase K (100 µg ml-1) at 2-h intervals. As shown in Figure 3-2B, the addition
of proteinase K detached the entire biofilm at every time point tested. Taken together
with the DNase I data, these results indicate that the attachment and multiplication
stages are dependent on protein components produced by the bacteria.
In an attempt to identify specific proteins important in the attachment and
multiplication stages, we utilized the BioFlux system to screen the Nebraska Transposon
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Figure 3-2 Effects of exogenous proteinase K and DNase I on biofilm attachment
and multiplication
S. aureus wild-type (UAMS-1) biofilms were grown in the BioFlux system with (open
circles) or without (closed circles) exogenously added (A) DNase I (0.5 U ml−1) or (B)
proteinase K (100 µg ml−1) at 0, 2, 4, and 6 h after the initiation of the experiment.
Arrows in graphs indicate time points at which either proteinase K or DNase I was added
to developing biofilm. Each graph shows the mean percentage of biofilm coverage in 2-h
intervals. The data represent the means from two independent experiments, each
containing at least two technical replicates. Error bars show the standard errors of the
means (176) from the two independent experiments.
Figure modified from Moormeier et al. 2014. mBio.
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Mutant Library (NTML) (155) for mutants that are defective in the production of
MSCRAMM proteins, including fibronectin-binding proteins A and B (FnbA and FnbB)
(78), Empbp (177), clumping factors A and B (ClfA and ClfB) (81, 82), Protein A (178),
elastin-binding protein (EbpS) (179), Sas family proteins (180, 181), and serineaspartate repeat (Sdr) family proteins (79, 80). In addition, we examined a srtA mutant,
which is defective in the processing of several LPXTG-motif containing MSCRAMM
proteins into the cell wall (182). However, none of these mutants exhibited observable
changes in biofilm development when grown in the BioFlux system (Table 3). We also
selected mutants defective in the production of secreted proteins such as the as α- and
β-hemolysins, which have been previously shown to play a role in biofilm development
(108, 183) (Table 3). Again, no noticeable differences in biofilm formation were
observed. Finally, we also tested an atlA mutant, in which the primary autolysin is
disrupted, for early biofilm defects. Consistent with previous findings (104), we saw
limited cell attachment and no biofilm multiplication (Figure 3-3) using this strain,
suggesting its role in these early stages of biofilm formation. In addition, we added PAS,
an autolysis inhibitor, in two hour time points to developing UAMS-1 wild-type biofilms in
the BioFlux100 and saw abolishment of the biofilm development (Figure 3-4). Overall,
these results support a role for Atl in biofilm attachment and/or multiplication, but fail to
identify a role for other cell surface and secreted proteins in these processes, although
the requirement for a combination of proteins cannot be ruled out.

Exodus is mediated by staphylococcal nuclease
Quorum sensing is the coordinated expression of genes in response to cell
density. In S. aureus, it is accomplished through the Agr system, which contributes to
biofilm dispersal after tower development through activation of proteases and PSMs
(111, 117). Thus, we hypothesized that this exodus stage is also controlled by the Agr
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Table 3. NTML mutants screened for involvement in early biofilm development
NTML
a
NE #

S. aureus
USA300_FPR3757
Locus

NE186

SAUSA300_2441

fnbA

Putative Protein
Fibronectin binding protein A

NE728

SAUSA300_2440

fnbB

Fibronectin binding protein B

+

NE543

SAUSA300_0772

clfA

+

NE391

SAUSA300_2565

clfB

NE1558

SAUSA300_0774

empbp

NE1561

SAUSA300_1370

ebps

NE286

SAUSA300_0113

(spa)

NE56

SAUSA300_1702

(sasC)

NE825

SAUSA300_2436

(sasG)

NE33

SAUSA300_2589

-

NE851

SAUSA300_0883

-

NE1

SAUSA300_1327

-

NE1787
NE1363
NE460

SAUSA300_2467
SAUSA300_1034
SAUSA300_0955

srtA
srtB
atlA

NE37

SAUSA300_2600

icaA

NE1167

SAUSA300_2601

icaB

NE766

SAUSA300_2602

icaC

NE302

SAUSA300_0152

cap5A

NE1235

SAUSA300_0156

cap5E

NE1286

SAUSA300_2598

cap1A

NE67
NE1746
NE1354
NE1261

SAUSA300_2573
SAUSA300_2088
SAUSA300_1058
SAUSA300_1973

isaB
luxS
(hla)
(hlb)

Clumping factor A
Clumping factor B
Secretory extracellular matrix
and plasma binding protein
Cell surface elastin binding
protein
Immunoglobulin G binding
protein A precursor
Cell wall surface anchor family
protein
Putative cell wall surface anchor
family protein
LPXTG-motif cell wall surface
anchor family protein
Putative surface protein
Cell surface protein
Sortase A
Sortase B
Autolysin
N-glycosyltransferase
Intercellular adhesion protein B
Intercellular adhesion protein C
Capsular polysaccharide
biosynthesis protein Cap5A
Capsular polysaccharide
biosynthesis protein Cap5E
Capsular polysaccharide
biosynthesis protein Cap1A
Immunodominant antigen B
S-ribosylhomocysteinase
Alpha-hemolysin
Truncated-beta hemolysin

b

Gene
Name

d
c

Biofilm
Phenotype
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Colors indicate functional group: red, LPXTG-motif surface proteins; green, LPXTG-motif protein processing; grey,
autolysin; blue, extracellular polysaccharide biosynthesis; orange, other secreted and surface proteins
a
NE# are obtained from Nebraska Transposon Mutant Library (NTML) website (http://app1.unmc.edu/fgx/)
b
Gene names are from NTML website. (gene name) indicates gene that is not annotated in the USA300_FPR3757
genome, but replaced with a gene name annotation from other S. aureus genomes with similar gene identity. – indicates
a putative/hypothetical protein not yet annotated.
c
Putative proteins as described on NTML website.
d
+ indicates no changes in early S. aureus biofilm development (0-8hr) compared to JE2 wild-type. – indicates early S.
aureus biofilms defective in either biofilm attachment or accumulation (0-8 hr).
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Figure 3-3 Effect of USA300 JE2 atlA mutant on early biofilm formation
The S. aureus wild-type (USA300 LAC JE2) and atlA::ΦΝΣ mutant derivative strains
were grown in the BioFlux system. Bright-field microscopic images were acquired in 5min intervals at ×200 magnification. Images at 1 h, 3h, and 6 h are representative of
multiple experiments. Note the clumping in the atlA::ΦΝΣ mutant and the lack of biofilm
at 6 h. Scale bar, 50 µm.
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Figure 3-4 Addition of PAS to UAMS-1 wild-type biofilms inhibits proper biofilm
development
S. aureus wild-type (UAMS-1) biofilms were grown in the BioFlux system with (184) or
without (blue) exogenously added PAS (500 µg ml-1) at 0, 2, 4, and 6 h after the initiation
of the experiment. Arrows in graphs indicate time points at which PAS was added to
developing biofilm. Each graph shows the mean percentage of biofilm coverage in 2-h
intervals. The data represent the means from two independent experiments, each
containing at least two technical replicates. Error bars show the standard errors of the
means (176) from the two independent experiments.
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quorum-sensing system. To test this, we obtained an agr::tet mutant (UAMS-155)
derivative of UAMS-1 and observed its ability to form a biofilm as described above.
Interestingly, although the agr::tet mutant exhibited increased initial attachment and
biofilm multiplication, exodus of a subpopulation was still clearly evident (Figure 3-5),
indicating that this event is largely independent of the Agr system. These results were
not specific to this strain as an agrA::ΦΝΣ transposon mutant of JE2 displayed a similar
pattern of exodus during this time period (Figure 3-6). Since previous studies have
demonstrated that the Agr P3 promoter is activated in a subpopulation of cells in S.
aureus biofilms (110, 117), we also tested a GFP reporter that was driven by the Agrdependent P3 promoter. Consistent with the lack of involvement of agr in this exodus
event, no P3 promoter activity was detected in the UAMS-1 strain until 13 hours of
biofilm growth, where expression was primarily limited to the towers (Figure 3-7) as
previously observed (110). Collectively, these findings indicate that the exodus of the
biofilm population observed in these assays are independent of the Agr quorum-sensing
system, and that this event is distinct from the previously described Agr-dependent
dispersal of cells that occurs after tower formation.
S. aureus synthesizes a myriad of extracellular proteins, the stability and
processing of which are modulated by ten secreted proteases (34). Our observation that
proteinase K disrupted biofilms suggests that S. aureus secreted proteases may play a
role in the biofilm exodus event. Indeed, recent studies have demonstrated that the
staphopain proteases can modulate biofilm integrity (33). However, a USA300 LAC
derivative deficient in all ten secreted proteases (AH1919) (156) showed no defects in
exodus of the biofilm subpopulation when compared to its parental strain (AH1263)
(Figure 3-8), suggesting that this event is independent of these proteases. In this regard,
several reports have demonstrated that deletion of the secreted nuclease (Nuc) in S.

% Biofilm Coverage

47

40
35
30
25
20
15
10
5
0

WT
agr::tet
icaA::ΦΝΣ
0

2

4
6
Time (h)

8

Figure 3-5 Effect of UAMS-1 agr and icaA mutations on early biofilm development
The S. aureus agr and icaA mutant strain, UAMS-155 (agr::tet) and KB8037 (icaA::
ΦΝΣ, respectively, were inoculated in parallel with UAMS-1 (wild type) in the BioFlux
system and allowed to form a biofilm for 18 h (A) Images selected at 4 h and 8 h are
representative of wild-type (185) and agr::tet biofilms from multiple experiments. Scale
bar, 50 µm. (B) The graph depicts the percentage of biofilm coverage in 15-min intervals
of wild-type (185), agr::tet, and icaA:: ΦΝΣ mutants biofilms over 8 h of growth. The data
represent the means from two independent experiments, each containing three technical
replicates. Error bars show the SEM from the two independent experiments.
Figure modified from Moormeier et al. 2014. mBio.
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Figure 3-6 Early biofilm development in the S. aureus USA300 LAC JE2 strain with
agrA, nuc, and, icaA mutant derivatives
The S. aureus wild-type (USA300 LAC JE2), agrA::ΦΝΣ, nuc::ΦΝΣ, and icaA::ΦΝΣ
mutant derivatives were grown in the BioFlux system. Bright-field microscopic images
were acquired in 5-min intervals at ×200 magnification. Images at 4 h and 8 h are
representative of multiple experiments. Scale bar, 50 µm.
Figure modified from Moormeier et al. 2014. mBio.
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Figure 3-7 Expression of Agr-dependent P3 promoter fusion in biofilm formation
UAMS-1 wild-type S. aureus cells containing the Agr P3::gfp reporter (pKH4) plasmid
were inoculated into a BioFlux microfluidic system and allowed to form a biofilm within a
flow shear environment at a flow rate of 64 μl/h for a total of 18 h. Bright-field and
epifluorescence microscopic images were collected at 5-min intervals at ×200
magnification. The images presented were taken from the complete set of 217 images
spanning 0 to 11 h and illustrate typical tower development and GFP expression
observed in multiple experiments. Note the lack of P3 expression during early biofilm
development (<11 h), and the P3 induction in the large tower. The scale bar represents
50 μm.
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Figure 3-8 Effect of ten major secreted proteases on early biofilms
The S. aureus wild-type strain (AH1263) and a mutant derivative lacking all 10 major
secreted proteases (AH1919) were grown in the BioFlux system. Bright-field microscopic
images were acquired in 5-min intervals at ×200 magnification. Images at 4 h and 8 h
are representative of three independent experiments with at least two technical
replicates. Scale bar, 50 µm.
Figure modified from Moormeier et al. 2014. mBio.
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aureus causes an increase in biofilm formation as a result of decreased eDNA
degradation in the biofilm ECM (100, 119, 122). Based on this, we hypothesized that
exodus of the biofilm population is mediated by the function of staphylococcal nuclease
in the degradation of eDNA. To test this, we cultured biofilms produced by the wild-type
(UAMS-1) and Δnuc mutant (UAMS-1471) strains harboring a ‘leaky’ anhydrotetracycline
(aTet)-inducible expression vector (pRMC2-nuc) driving low-level nuc transcription, and
then quantified the coverage of the developing biofilm as described above. In support of
a role for nuclease in the exodus event, the Δnuc mutant containing the empty vector
(pRMC2) failed to initiate exodus, which resulted in considerably thicker biofilms
compared to the wild-type harboring either pRMC2 or pRMC2-nuc (Figure 3-9A).
Quantification of the biofilm over the first eight hours showed considerably more biofilm
present past six hours of growth in the ∆nuc mutant containing pRMC2 and a reversion
to wild-type levels of exodus when grown with pRMC2-nuc (Figure 3-9B). To determine if
this phenomenon was conserved in another S. aureus strain, we also grew wild-type JE2
and its nuc mutant derivative (nuc::ΦΝΣ) biofilms in parallel. Like the UAMS-1 strain, the
nuc::ΦΝΣ mutant demonstrated biofilm growth that lacked the exodus event,
accumulating to a higher cell density over time compared to the wild-type JE2 strain
(Figure 3-6). Together, these data demonstrate that the S. aureus secreted nuclease
plays a major role in the exodus of the biofilm population prior to tower formation and
suggests nuclease insensitivity before the exodus event occurs.
To determine if the exodus defect in the Δnuc mutant could be restored by the
addition of exogenous nuclease, we grew wild-type, Δnuc mutant, and nuc complement
biofilms with or without media supplemented with DNase I (0.5 Units ml-1) starting at the
0-h time point. As shown in Figure 3-10, the addition of DNase I had little effect on
biofilm multiplication or exodus in the wild-type strain. In contrast, the presence of
DNase I caused exodus of the Δnuc mutant biofilm, but not until approximately six hours
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Figure 3-9 Exodus requires staphylococcal nuclease
Biofilms of the S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) containing
pRMC2 or pRMC2-nuc were grown in the BioFlux system. (A) Selected bright-field
images at 4 h and 8 h are representative of bioflims of the wild-type (UAMS-1) or Δnuc
mutant (UAMS-1471) containing pRMC2 or pRMC2-nuc from multiple experiments.
Scale bar, 50 µm. (B) The graph shows the mean percentage of biofilm coverage in 15min intervals of biofilms of the wild-type (UAMS-1) and Δnuc mutant (UAMS-1471)
containing pRMC2 or pRMC2-nuc over 8 h of growth. The data represent the means
from two independent experiments, each containing at least three technical replicates.
Error bars show the SEM from the two independent experiments.
Figure modified from Moormeier et al. 2014. mBio.
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Figure 3-10 Functional complementation of the nuc mutant biofilm phenotype by
addition of DNase I
S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) cells were grown in the
BioFlux with or without DNase I (0.5 U ml−1). The graph shows the mean percentage of
biofilm coverage in 15-min intervals of wild-type (185) and Δnuc biofilms grown in the
presence or absence of DNase I. The data represent the means from two independent
experiments, each containing three technical replicates. Error bars show the SEM from
the two independent experiments.
Figure modified from Moormeier et al. 2014. mBio.
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of biofilm development when the exodus event is normally observed (Figure 3-10). To
assess whether nuclease insensitivity prior to six hours was a result of the absence of
eDNA in the matrix during this time, we isolated eDNA at four hours from wild-type
(UAMS-1) and ∆nuc mutant (UAMS-1471) biofilms grown in the absence or presence of
active DNase I (0.5 Units ml-1). Although eDNA is clearly detectable during the
multiplication stage and there is a trend toward differences in the levels of eDNA present
between the DNase I treated and untreated biofilms, both wild-type and ∆nuc mutant
biofilms cultured with and without DNase I showed no significant differences in eDNA
levels (Figure 3-11) suggesting that there is some protection from the activity of this
nuclease by other components of the biofilm matrix.

Biofilm exodus is preceded by nuclease expression
The data generated so far demonstrates that biofilm exodus is reproducibly
initiated in a nuclease-dependent manner at approximately six hours after the initiation of
biofilm development. Based on these results, we hypothesized that nuc expression
would precede biofilm exodus at approximately six hours. To test this, the UAMS-1 and
JE2 strains containing a previously constructed nuc::gfp promoter fusion plasmid
(pCM20) were studied to determine the temporal expression of nuc during biofilm
development. As anticipated, nuc expression was induced just prior to the exodus event
at six hours, albeit in only a subpopulation (<1%) of the cells (Figure 3-12). To quantify
the induction of nuc expression, we set a threshold that would enumerate all of the light
objects (fluorescent cells) in each image and plotted this as percent fluorescence
coverage over time. As seen in Figure 3-13, nuc expression was initially observed at
three hours and maximally expressed near five hours of biofilm growth, preceding biofilm
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Figure 3-11 Quantification of eDNA isolated from BioFlux biofilms
S. aureus wild-type (UAMS-1) and Δnuc mutant (UAMS-1471) biofilms were grown with
or without active DNase I (heat-inactivated 10 min at 95°C) for 4 hours in the BioFlux
system in four identical channels. After 4 hours of biofilm growth, eDNA was isolated as
described in Materials and Methods. The data represent the means from two
independent experiments, each containing three technical replicates. Error bars show
the SEM from the two independent experiments.
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Figure 3-12 Expression of nuc precedes exodus of a biofilm subpopulation
S. aureus wild-type UAMS-1 and JE2 cells containing the nuc::gfp reporter plasmid
(pCM20) were grown in the BioFlux system. Bright-field and epifluorescence microscopic
images were acquired in 5-min intervals at ×200 magnification. (A) Bright-field and
epifluorescence (GFP) images at 2 h and 5 h are representative of multiple experiments
of UAMS-1 pCM20. Scale bar, 20 µm. (B) The plot depicts biofilm growth as the mean
percentage of UAMS-1 pCM20 biofilm coverage and the nuc-expressing cells as the
mean fluorescence coverage in 15-min intervals over 8 h of growth. The data represent
the means from two independent experiments, each containing at least two technical
replicates. Error bars were omitted for clarity.
Figure modified from Moormeier et al. 2014. mBio.
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exodus. These results indicate that both temporal and stochastic regulatory mechanisms
control nuc promoter activity during biofilm development.
The Sae two-component regulatory system controls nuc-mediated exodus
Previous results have shown that the Sae two-component system regulates
nuclease expression (48). Hence, to gain insight into the regulation of the exodus event,
we tested wild-type AH1263 (USA300 LAC derivative) and its saeQRS::spc mutant
(AH1558) for biofilm development and nuc expression. Consistent with its role as a
positive regulator of secreted nuclease, the saeQRS::spc mutant biofilm developed in a
way that was similar to a nuc mutant, lacking biofilm exodus and accumulating to a high
cell density (Figure 3-13). However, the saeQRS::spc mutant also exhibited an apparent
decrease in the rate of biofilm multiplication suggesting a role for this regulator in the
production of some factor(s) important in this process. Additionally, the saeQRS::spc
mutant demonstrated much reduced nuc expression compared to wild-type AH1263
(Figure 3-13), indicating that the temporal and/or stochastic control of nuc expression
requires the Sae regulatory system.
To continue to dissect the function that the Sae system has in regulating nuc
expression and biofilm development, we obtained clean deletion mutations in saeP,
saeQ, saeS, and saePQRS in the AH1263 strain background and moved the Pnuc::gfp
(pCM20) fluorescent reporter fusion into these genetic backgrounds. To determine if
these mutations had any effect on growth, we grew them aerobically for 24 hours in TSB
containing 0.25% glucose. Under these growth conditions, we saw no major growth
defect demonstrating that these mutations do not have a direct function in regulating
expression of genes involved in growth (Figure 3-14). To investigate the effects of the
sae mutations on biofilm and nuc expression, we cultivated these sae mutants
containing pCM20 in the BioFlux1000 to allow for biofilm formation.
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Figure 3-13 Nuclease-mediated exodus is regulated by Sae
S. aureus wild-type (AH1263) and saeQRS::spc mutant (AH1558) strains carrying
the nuc::gfp reporter plasmid (pCM20) were grown in the BioFlux system. Bright-field
and epifluorescence (GFP) microscopic images were acquired in 5-min intervals at ×200
magnification. Images at 2, 5, and 8 h are representative images from two independent
experiments. Scale bar, 50 µm. The plot depicts biofilm growth as the mean percentage
of biofilm coverage and the nuc-expressing cells as the mean fluorescence coverage in
15-min intervals over 8 h of growth. The data represent the means from two independent
experiments, each containing at least two technical replicates. Error bars were omitted
for clarity.
Figure modified from Moormeier et al. 2014. mBio.
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Figure 3-14 Growth analysis of sae mutants containing pCM20 grown
planktonically
S. aureus AH1263 (185) and sae mutants containing Pnuc::gfp reporter fusion (pCM20)
were grown planktonically to determine effect on growth. Cultures were grown for 24
hours with shaking at 250 rpm at 37°C using a 10:1 flask to volume ratio. Subsequently,
supernatants were taken at 0, 3, 6, 9, 12 and 24 hours and the OD600 were measured
and plotted over time. Data represents two independent experiments performed in
duplicate.
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Similar to the sae::spc mutant described before (Figure 3-13), we saw little to no nuc
expression and an abrogated exodus stage in the ∆saeS and ∆saePQRS mutants
(Figure 3-15). In addition, the ∆saeQ mutant showed an intermediate phenotype in nuc
expression when compared to AH1263 and the ∆saeP strain (Figure 3-15). Interestingly,
however, the ∆saeP mutant had an unusual phenotype. While there was little to no nuc
expression during the first hours of biofilm development in a ∆saeP mutant biofilm, at
around 3-3.5 hours, instead of only a subpopulation of nuc expressing cells like in
AH1263 biofilm (Figure 3-13), the entire cell population expressed nuc (Figure 3-15).
Interestingly, although the entire cell population is expressing nuc, there was no effect
on the exodus stage itself (Figure 3-15). To determine if stochastic expression is
observed in planktonic cells, we grew AH1263 and the sae mutant derivatives containing
the Pnuc::gfp fluorescent reporter fusions for 3 hours in shaking flasks and then
performed fluorescence-activated cell sorting (FACS). Unlike the subpopulations of cells
expressing nuc in the parental and ∆saeQ strains during biofilm development, this effect
is lost during planktonic growth. Indeed, >98% of the cells are expressing nuc in all of
the strains except for the ∆saeS and ∆saePQRS mutants, which showed very little nucgfp positive cells (Figure 3-16). These results suggest that the stochastic expression of
nuc is a biofilm-specific phenotype not seen in planktonically growing cells. Collectively,
these data further demonstrate that the Sae system regulates the exodus stage of
biofilm development in a much more complex way than previously thought.
Several different stimuli have been shown to affect the induction of the Sae
system including SDS, H2O2, low pH, and sub-inhibitory concentrations of antibiotics and
α-defensin (HNP-1) (157, 186-189), yet, the exact molecular mechanism in which the
Sae system is activated is not known.
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Figure 3-15 Effect of Sae mutations on nuc expression and early biofilm
development
S. aureus wild-type AH1263, ∆saeP, ∆saeQ, ∆saeS, and ∆saePQRS mutant derivative
strains carrying the nuc::gfp reporter plasmid (pCM20) were grown in the BioFlux
system. Bright-field and epifluorescence (GFP) microscopic images were acquired in 5min intervals at ×200 magnification. Images at 2, 5, and 8 h are representative images
from two independent experiments. Scale bar, 50 µm.
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Figure 3-16 FACS analysis of nuc expressing cells grown planktonically
S. aureus AH1263 (185) and sae mutants containing Pnuc::gfp reporter fusion (pCM20)
were grown planktonically for 4 hours with shaking at 250 rpm at 37°C using a 10:1 flask
to volume ratio. Cells were then washed with 1x PBS and 10,000 events of each culture
sample were counted using fluorescence-activated cell sorting (FACS) to determine
number of GFP-positive cells. Data was plotted using FlowJo software and is
representative of three biological replicates.
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Additionally, most of these stimuli are not found in our in vitro biofilm conditions. Hence,
we wanted to continue to evaluate how the Sae system is activated in S. aureus biofilms.
Effect of exogenous DNA on planktonic S. aureus cells
Initial data generated from the Horswill laboratory demonstrates that the
extracellular lipoprotein SaeP binds eDNA (unpublished data from Horswill lab). Given
that the Sae system controls nuclease which degrades eDNA within a biofilm, we
hypothesized that eDNA may be the signal that the Sae system is sensing to control
expression of nuclease. Therefore, we added exogenous salmon sperm DNA to a wildtype strain containing the Pnuc-gfp reporter fusion biofilms grown in the BioFlux1000 to
see if it would have an effect on nuc expression. To our surprise, the exogenously added
DNA essentially wiped out the biofilms (Figure 3-17) making it impossible to evaluate its
effect on nuc expression and suggesting that the additional DNA has an inhibitory effect
on S. aureus biofilm development. Due to the inhibitory effect of exogenous DNA on S.
aureus biofilm development, we decided to evaluate the influence that exogenous DNA
may have on nuc expression in planktonic cells. Thus, we added increasing percentages
(w/v) of salmon sperm DNA to planktonically growing wild-type cells containing the
Pnuc::gfp reporter fusion. Surprisingly, we saw an indirect relationship between
increasing amounts of DNA and decreasing amounts of nuclease expression at 3 hours
of growth (Figure 3-18). However, at six hours of growth, the effect of added DNA on nuc
expression was not as strong (Figure 3-19). Interestingly, we also saw that the addition
of the 2% DNA caused a slight growth defect in wild-type cells (data not shown). Hence,
when we sought to determine if a ∆saeP mutant would abrogate the effect of adding
exogenous DNA seen in wild-type cells, we excluded 2% DNA in further analyses.

66

Figure 3-17 Effect of exogenous DNA on biofilm development
S. aureus wild-type (UAMS-1) cells were grown in the BioFlux with or without salmon
sperm DNA (1 µg ml−1). The graph shows the mean percentage of biofilm coverage in at
six of UAMS-1 wild-type (185) biofilms grown in the presence or absence of DNA. The
data represent the means from two independent experiments, each containing at least
two technical replicates. Error bars show the SEM from the two independent
experiments.
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Figure 3-18 Effect of exogenous DNA on nuc expression in planktonic AH1263
wild-type cells
AH1263 wild-type and ∆saePQRS strains containing Pnuc::gfp reporter fusion (pCM20)
were grown for 3 or 6 hours in TSB containing 0.25% glucose buffered in 50 mM 3-(Nmorpholino)propanesulfonic acid (MOPS) at pH 7.4 with or without different percentages
of exogenous salmon sperm DNA. Fluorescence (nuc expression) was quantified using
a Tecan Infinite 200 spectrofluorometer with an excitation wavelength of 490 nm and
emission wavelength of 525 nm. Relative fluorescence was determined by normalizing
the quantified fluorescence per OD600 and plotted using GraphPad Prism. Data
represents the averages from two independent experiments performed in duplicate.
Error bars show the SEM from the two independent experiments.
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Figure 3-19 Effect of exogenous DNA on nuc expression in planktonic ∆saeP cells
AH1263 wild-type (184) and ∆saeP (blue) strains containing Pnuc::gfp reporter fusion
(pCM20) were grown for 3 or 6 hours in TSB containing 0.25% glucose buffered in 50
mM 3-(N-morpholino)propanesulfonic acid (MOPS) at pH 7.4 with or without different
percentages of exogenous salmon sperm DNA. Fluorescence (nuc expression) was
quantified using a Tecan Infinite 200 spectrofluorometer with an excitation wavelength of
490 nm and emission wavelength of 525 nm. Relative fluorescence was determined by
normalizing the quantified fluorescence per OD600 and plotted using GraphPad Prism.
Data represents the averages from two independent experiments performed in duplicate.
Error bars show the SEM from the two independent experiments.
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Remarkably, there were little differences seen between the wild-type and the ∆saeP
mutant at both three and six hours (Figure 3-20) suggesting that the SaeP protein may
not be the sole contributor to the decrease in nuclease expression in the presence of
added DNA, at least under these planktonic conditions.
Given the data that shows a decrease in nuc expression in response to
increasing amounts of DNA, we also sought to determine if there were any effects on
overall S. aureus growth in both wild-type, ∆saeP, and ∆saePQRS strains. Therefore, we
grew these strains in the presence of increasing amounts of DNA and plotted the OD600
over time. Interestingly in the AH1264 wild-type strain, increased amounts of DNA
resulted in larger growth yields at 6-12 hours, yet, there were no differences at 24 hours
(Figure 3-20; top color row panels). However, there were no difference between wildtype and the ∆saeP and ∆saePQRS strains at various percentages of DNA (Figure 3-20;
bottom black row panels). This suggests that S. aureus may be able to utilize extra DNA
as an additional carbon source to cause increases in growth yield or perhaps a reduction
in autolysis, though, this ability appears to be independent of the Sae system.

Other Sae-controlled factors demonstrate stochastic expression similar to
nuclease
Since the Sae system controls a myriad of other factors, and nuclease is
stochastically expressed within a biofilm, we hypothesized that other Sae-controlled
factors may be regulated similarly within a biofilm. To test this hypothesis, we obtained
hla (α-toxin), hlgA (γ-toxin), and P1sae fluorescent reporter fusions in AH1263 wild-type
and sae mutant strains and cultivated biofilms in the BioFlux1000.
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Figure 3-20 Effect of exogenous DNA on planktonic growth
AH1263 wild-type, ∆saeP, and ∆saePQRA strains containing Pnuc::gfp reporter fusion
(pCM20) were grown for 24 hours in TSB containing 0.25% glucose buffered in 50 mM
3-(N-morpholino)propanesulfonic acid (MOPS) at pH 7.4 with or without different
percentages of exogenous salmon sperm DNA. OD600 were taken at 0, 1, 2, 3, 4, 5, 6 7,
8, 9, 10, 11, 12, and 24 hours and plotted over time using GraphPad prism. Data
represents the averages from two independent experiments performed in single flasks.
Error bars show the SEM from the two independent experiments. Top row panels
(colored) show relation of different percentages of DNA in one strain of S. aureus.
Bottom two row panels (black) show relation of wild-type and sae mutants when grown
with a certain percentage of exogenous DNA.
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Figure 3-21 Expression of Sae-regulated genes hla, P1sae, and hlgA during biofilm
development
S. aureus wild-type AH1263 (185) strain and the ∆saeS mutant derivative strain carrying
the Phla::gfp (pCM27), PhlgA::gfp (pCM11hlgA), and P1sae::gfp (pcm11P1sae) reporter
plasmids were grown in the BioFlux system. Brightfield and epifluorescence (GFP)
microscopic images were acquired in 5-min intervals at ×200 magnification. Images are
at 5 h and are representative images from two independent experiments at least in
triplicate. Scale bar, 50 µm.
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Strikingly, in support of our hypothesis, the hla and P1sae reporter fusions demonstrated
Sae-dependent stochastic expression (Figure 3-21) similar to nuc (Figures 3-12, 3-13, 315). In contrast, the hlgA reporter showed no expression under our biofilm conditions
(Figure 3-21). This is not completely unexpected given the recent results suggesting that
hlgA is part of the Sae regulon that requires activation by external host signals (157).
Given that the hla and P1sae reporters demonstrated similar expression to nuc in
a developing biofilm, we sought to characterize whether or not cells expressing nuc were
also expressing other Sae-regulated genes. Thus, we generated a dual fluorescent
reporter plasmid (pDM19) containing the promoter regions of nuc and coa
(staphylocoagulase) and transduced it into AH1263 and sae mutants to simultaneously
evaluate expression of two Sae-controlled genes during biofilm development.
Remarkably, coa and nuc demonstrated identical stochastic expression patterns with
only a subpopulation of cells expressing the fluorescent reporters in AH1263 wild-type
strain (Figure 3-22). Additionally, much like the nuc expression studies described above,
both the coa and nuc reporters were expressed in nearly every cell in the ∆saeP mutant
biofilm. Also, little to no expression of either reporter was observed in the ∆saePQRS
mutant (Figure 3-22). Altogether, these data suggest that the Sae system coordinates
the expression of some Sae-regulated factors in a way that only initiates expression in a
subpopulation of cells.
DISCUSSION
Our current understanding of S. aureus biofilm development is based on the
characterization of three basic steps: 1) attachment, 2) accumulation/maturation, and 3)
detachment/dispersal (76). The complexity of these processes was first highlighted in a
study by Yarwood et al. (110) who used time-lapse video microscopy to visualize waves
of growth and detachment that appeared to coincide with agr expression. More recent
studies have revealed that detachment is largely dependent on expression of surfactant-
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Figure 3-22 coa and nuc are expressed in the same subpopulation during biofilm
development
S. aureus wild-type AH1263 (185), ∆saeP, and ∆saePQRS mutant derivative strains
carrying the Pnuc::gfp Pcoa::sdred dual reporter plasmid (pDM19) were grown in the
BioFlux system. Brightfield and epifluorescence (GFP and sDsRed) microscopic images
were acquired in 5-min intervals at ×200 magnification. Images are at 5 h and are
representative images from two independent experiments at least in duplicate. Scale
bar, 50 µm.
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like molecules known as phenol-soluble modulins (PSMs) (117). In the current studies,
we applied BioFlux microfluidics technology to provide enhanced resolution ofthe events
occurring during the early stages of S. aureus biofilm development. In doing so, we have
identified two additional developmental stages referred to as “multiplication” and
“exodus” (Figure 3-1), which are distinct from the agr-mediated dispersal events that
occur after tower formation. In addition, these studies provide greater insight into tower
development associated with biofilm maturation, as well as the complex regulatory
strategies that precede this process.

Attachment
The observation that the initial attachment of cells to the substrate could be
inhibited by the addition of proteinase K indicates that this process is mediated by
protein components associated with the cells (Figure 3-2B). Given that the Agr system is
known to regulate expression of secreted and cell wall-associated proteins in S. aureus
(190), we tested this strain for its ability to attach in our biofilm assay. As shown in
Figure 3-5B, we observed an increase in cell attachment in an agr mutant derivative of
the UAMS-1 strain. This observation is consistent with a previous report showing that
agr-defective strains exhibit increased adherence to polystyrene in static biofilm assays
(85). Within this study, it was demonstrated that increased attachment of the agr mutant
strains was the result of decreased production of the PSM, δ-toxin, which these authors
speculated may act as a strong surfactant preventing hydrophobic interactions between
the cell surface and the polystyrene substrate.
In fact, S. aureus produces numerous surface proteins including the Sas family of
proteins, fibronectin-binding proteins, clumping factors, elastin-binding proteins, protein
A, and AtlA that have all been shown to be important for attachment and biofilm
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maturation (86, 170). To determine the potential role of these proteins in our system, we
identified NTML mutant strains, as well as others, that contain defects in the synthesis of
cell surface-associated molecules (i.e. LPXTG-motif proteins, intercellular adhesion, and
capsule) and screened them for initial attachment (Table 3). This analysis revealed that
only the atlA::ΦΝΣ mutant exhibited a defect in the initial attachment of cells (Figure 33). In addition, we added PAS, an autolysis inhibitor, in two hour time points to
developing UAMS-1 wild-type biofilms in the BioFlux1000 and saw abolishment of the
biofilm two hour following addition of PAS (Figure 3-4). These data are in agreement
with a recent study that demonstrates that the S. aureus biofilm matrix relies less on cell
surface-associated proteins including protein A and the fibronectin-binding proteins, and
more so on cytoplasmic proteins released during stationary phase of growth (191). In
addition, while AtlA has been reported to serve as an adhesin (86), results have also
indicated that the enzymatic activity of this protein is required for biofilm formation,
suggesting the involvement of autolysis and the subsequent release of genomic DNA
(104). Arguing against this possibility is the observation that the addition of DNase I to
the inoculum (data not shown) or at the 0-h time (Figure 3-2A) had little effect on the
attachment of cells. Complicating the interpretation of these results further is the
propensity of the atlA mutant to form large clusters of cells, which could have detrimental
effects on cell attachment. Furthermore, the fact that many of the mutants tested did not
show a defect in biofilm development is not completely unexpected since most of the
surface proteins are important for binding host matrix components (i.e. MSCRAMMs),
which are absent in our biofilm assays. Overall, the finding that attachment was affected
by the agr and atlA mutations, but none of the other cell surface protein mutations, is
consistent with the hypothesis that AtlA and δ-toxin are required for this process (85).
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Multiplication
Similar to cell attachment, the multiplication stage was also found to be sensitive
to protease treatment (Figure 3-2B); however, screening of the NTML for proteins
involved in this stage failed to identify a protein important in this process (Table 3). The
current studies demonstrated that DNase I had little effect on the biofilm during the
multiplication stage (Figure 3-2A and Figure 3-10). This is in agreement with a recent
study demonstrating DNase I-insensitivity during early S. aureus biofilm development
(175). Although these results appear to conflict with our previous findings (99, 100), it is
important to note that the biofilm growth conditions used here were distinctly different
from the static assay conditions used previously. In addition, the BioFlux assay affords
greatly increased resolution of the early events in biofilm maturation through real-time
microscopic imaging of the cells, thus, enabling the visualization of developmental
events that were previously undetectable in the static assays. In addition, isolation of
eDNA from the biofilms at four hours treated with or without active DNase I showed no
significant changes in eDNA levels although the eDNA levels were lower when treated
(Figure 3-11). Based on these data, we hypothesize that there is a functional shift in the
biofilm matrix prior to the exodus event from a protein-based matrix to one that is
dependent on both eDNA and protein, most likely the result of eDNA and protein
interactions occurring as the biofilm matures. Indeed, precedence for this includes the
demonstration that S. aureus beta toxin, normally known for its role as a hemolysin, can
bind eDNA and covalently cross-link to itself forming an insoluble nucleoprotein matrix
within a biofilm (108). However, UAMS-1 does not produce beta toxin due to an insertion
of the bacteriophage in the hlb gene (108). Like beta toxin, the immunodominant surface
antigen B (IsaB) has also been shown to bind DNA, yet an isaB mutant previously
exhibited no defect in biofilm formation (109). Likewise, an isaB mutant showed no
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noticeable differences in biofilm development when grown in the BioFlux1000 when
compared to it wild-type strain (data not shown).
In contrast to these extracellular DNA-binding proteins, recent reports have
demonstrated that cytoplasmic nucleoid-associated proteins (NAPs), normally known for
intracellular chromosomal structuring, have emerged as possible biofilm scaffolds in
different bacteria. Specifically, biofilm produced by Burkholderia cenocepacia, nontypeable Haemophilus influenza, and Escherichia coli have all shown a requirement for
integration host factor (IHF) and/or histone-like protein (HU). In fact, treatment of
established biofilms of these species, as well as S. aureus and S. epidermidis, with
antisera specific for these proteins resulted in a considerable decrease in the total
amount of biofilm generated (107, 192). The precedence for NAPs in bacterial biofilms
and the plethora of NAPs identified in S. aureus (193) suggest that these proteins may
be important contributors to biofilm development in S. aureus. Studies to identify specific
eDNA-binding proteins important in biofilm integrity are currently in progress in our
laboratory.

Exodus
The observation that Agr P3 promoter activity was not observed until well after
tower development (Figure 3-7), in combination with the absence of an effect of an agr
mutation on the exodus event (Figure 3-5), suggests that the Agr quorum-sensing circuit
and the PSMs are not required for exodus. Instead, given the role of eDNA in biofilm
development we hypothesized that staphylococcal nuclease may be required.
Consistent with this hypothesis was the observation that the biofilm became DNase Isensitive after six hours of development (Figure 3-10), and the Δnuc mutant failed to
initiate exodus at this time point (Figure 3-9). Given the precise timing of the exodus
event, we also examined nuc expression and, remarkably observed expression limited to
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subpopulation of cells preceding the exodus event (Figure 3-12), suggesting that these
specialized cells have an impact on the remainder of the biofilm population, much like
the specialization that is seen in Bacillus subtilis biofilm formation (194). In addition,
these data also suggest a model where early Nuc-mediated exodus allows for tower
formation and eventual late Agr-mediated dispersal for further dissemination of S.
aureus cells.
The observation that nuc exhibited temporal and stochastic patterns of
expression during biofilm development indicates that it is subject to complex regulatory
control. While previous reports have suggested that nuclease is regulated by the Agr
quorum-sensing circuit (195-197), new evidence demonstrates nuc expression is more
directly controlled by the Sae regulatory system (198-200). Indeed, recent promoter
mapping, Nuc activity measurements, and immunoblot studies have confirmed the Saedependent regulation of nuclease expression (48). In support of these findings, an agr
mutant exhibited both temporal and stochastic regulatory control of nuc expression
during biofilm development similar to the wild-type strain (data not shown). Additionally,
a saeQRS::spc mutant failed to initiate exodus of the biofilm population and exhibited
much reduced nuc expression when compared to its parental strain AH1263 (Figure 313). The saePQRS operon encodes two auxiliary proteins, SaePQ, and a twocomponent system, SaeRS, that globally regulate multiple S. aureus secreted proteases
(201) and virulence factors such as alpha toxin, beta toxin (hlb), coagulase (coa),
fibronectin-binding proteins (fnbA and fnbB), and extracellular adherence protein (eap)
(202, 203). To continue to dissect the potential roles that each protein in the saePQRS
operon has during nuc expression and biofilm development, we obtained mutations in
three of the four genes (i.e. ∆saeP, ∆saeQ, and ∆saeS) and a complete deletion of the
entire operon, ∆saePQRS. Most interestingly, the ∆saeP demonstrated a unique
phenotype where apparently every cell in the developing biofilm expressed nuclease
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compared to the subpopulation of cells seen in wild-type (Figure 3-15). This is
particularly significant given that work by another group has demonstrated that the SaeP
protein can bind eDNA (unpublished data from Alexander Horswill laboratory) and the
recent study proposing that the SaeP and SaeQ form a complex to initiate phosphatase
activity of the sensor kinase SaeS (203) may explain this unique expression phenotype.
Given the former, along with several examples of bacterial cells sensing their ECM to
initiate biofilm cell responses (204), we hypothesized that the SaeP protein may be
sensing eDNA as a feedback mechanism to control nuc expression during biofilm
development. Thus, we added exogenous DNA to the developing biofilm, and to our
surprise, the additional DNA almost completely prevented biofilm formation (Figure 317), making it impossible to evaluate nuc expression. Interestingly, this effect was similar
to that observed for PAS-treated biofilms, or cells that contain an atlA mutation (Figure
3-3), both of which are unable to form biofilms due to a lack of lysis. Considering the
recent data demonstrating that the glucosaminidase domain of AtlA binds DNA (205),
one possible explanation for this phenomenon is that exogenously added DNA is binding
to AtlA and inhibiting its function, and ultimately leading, to inhibition of biofilm
development. However, this possibility is still being investigated.
Since we were unable to add additional DNA to a S. aureus biofilm, we
performed

planktonic

studies

to

determine

any

effects

on

nuc

expression.

Counterintuitively, when increasing amounts of salmon sperm DNA were added to
planktonically growing cells, there was a clear decrease in nuc expression (Figure 3-18),
yet, it appeared to be SaeP-independent (Figure 3-19). This is in contrast to our
expectations considering if more of the substrate for nuclease (i.e. eDNA) is present,
one would imagine that an increase in nuclease activity would occur and the Sae-control
would be eliminated in a saeP mutant. However, this does not appear to be the case.
Nonetheless, one possible explanation for the increase in nuc expressing cells in the
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biofilm in a ∆saeP mutant may be due to the fact that SaeQ cannot form a complex with
SaeP and activate the phosphatase activity of SaeS resulting in uncontrolled expression
of nuclease throughout a biofilm.
In addition to evaluating the effect of exogenous DNA on nuc expression, we also
evaluated the effect of exogenous DNA on S. aureus overall growth. When DNA was
added from initial inoculation of planktonically grown cells, there is a clear increase in
growth yield from 6-12 hours when compared to strains grown in TSB not containing
additional DNA (Figure 3-20). Although this is not a Sae-controlled process (Figure 320), it seems that S. aureus may be able to use DNA as an additional carbon source.
This may be possible considering the primary carbon source, glucose, in TSB is
exhausted by six hours (154) and other bacteria such as Vibrio cholerae have shown the
ability to use DNA as a nutrient source (206). As an alternative hypothesis, the
exogenous DNA could be killing the cells but not lysing because the activity of Atl may
inhibited.
Lastly, considering that the Sae system regulates so many different genes, we
asked whether other Sae-regulated promoters, such as those driving hla, hlgA, P1sae,
and coa expression, demonstrated similar expression patterns in a developing S. aureus
biofilm. Surprisingly, the hla, P1sae, and coa promoters all showed similar stochastic
expression to nuc. In contrast, no hlgA expression was observed (Figure 3-21). In
addition, a coa/nuc dual reporter construct revealed overlapping expression patterns
(Figure 3-22), demonstrating that subpopulation of cells is responsible for the expression
of at least two different secreted proteins. While it is fascinating that these other Saeregulated factors appear to be stochastically regulated in subpopulation of cells, one
interesting observation amongst these data is the fact that hla and coa have similar
expression patterns even though they are in different “classes” of Sae regulation. These
classes refer to whether or not the expression of a particular gene is dependent on the

82
phosphorylation state of SaeR (202). Indeed, class I sae target genes (coa, fnbA, eap,
sbi, efb, fib, nuc, and sae) require phosphorylation of SaeR while the class II target
genes (hla, hlb, and cap) seem to be less reliant on this phosphorylated state (202).
Since the nuc and coa are in the same class, it is not surprising that the two genes are
expressed in the same biofilm population. This suggests that a Sae-regulated
mechanism is activated to control the overproduction of certain virulence factors and
delineate roles to certain subpopulations of cells. In addition, the data demonstrating
similar expression patterns between hla and nuc in a biofilm suggests that there may be
much more to the control of hla, yet, construction of a nuc/hla reporter could provide
further insight into whether or not both of these genes are expressed in the same biofilm
cell population. This additional control may be under the Agr quorum-sensing system,
given that the large 5’ untranslated region (5’ UTR) of hla mRNA can be bound by
RNAIII leaving the Shine-Dalgarno sequence to be bound by ribosomes and leaving hla
under translational control in addition to transcription regulation (207). In addition to hla
expression patterns, another observation that hlgA expression was undetectable even in
the wild-type strain. Recent data suggesting that hlgA expression is dependent on
activation by host cell antimicrobials such as α-defensin (157), may explain why it is not
expressed in an in vitro biofilm assay. Thus, further studies must be continued to
evaluate the regulation of these Sae-factors and others by examining not only Sae
control, but also the interplay of other regulators such as Agr or SarA or the newly
identified virulence factor regulatory locus, vfrAB operon, which appears to be an
upstream regulator of the Sae regulon (208)
Tower Maturation Stage
Based on the results of this study, it is apparent that the early exodus event
during S. aureus biofilm development is essential for the formation of distinct tower
structures, which based on our previous studies (148) have variable physiology and
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metabolism as seen by the presence or absence of eDNA and dead cells as well as
differential gene (cid and lrg) expression. However, two major questions remain to be
answered. First, how do these eDNA-containing towers remain intact if nuclease is
active? A recent report testing DNase I efficacy in UAMS-1 S. aureus biofilms
demonstrated carbohydrates (likely, PIA) and eDNA staining within tower structures and
appear to be DNase I insensitive (175). The authors suggest that carbohydrates may be
interacting with eDNA and protecting it from DNase I degradation, however, further
investigation must be conducted to confirm these findings.
Second, what is the function of towers in S. aureus biofilm? Some evidence
suggests that tower structures are important for the pathogenesis of S. aureus biofilms
formed on native heart valves of infective endocarditis where they detach and travel to
secondary sites of infection (64, 103, 209). In other organisms, the development of
specialized structures is important for survival and/or resistance to environmental
stresses. For example, the cystic fibrosis pathogen, Pseudomonas aeruginosa, forms
robust tower-like structures that have been shown to be important in resisting microbial
biocides such as sodium dodecyl sulfate (SDS) detergent and tobramycin (210, 211), as
well as mediating biofilm dispersal (138). Additionally, the predator bacterium,
Myxococcus xanthus, demonstrates complex multicellularity and intercellular signaling
through coordinated gene expression to form raised aggregates of cells called fruiting
bodies (212-214). Indeed, much like the reduction of the cell population during the
exodus phase that precedes tower formation in S. aureus, M. xanthus demonstrates a
reduction of the cell population preceding fruiting body development (215, 216). Based
on these similarities, it is likely that tower structures produced by S. aureus are also
important in survival during environmental stress.
Finally, the results of our studies suggest an alternative to the model proposed by
Otto (76) describing how S. aureus biofilms develop their characteristic structure. In this
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model, it is envisioned that the PSMs act upon a preexisting thick mat of cells, causing
cell detachment and leaving behind structures of various forms (e.g. towers and
channels). However, the structures present in the biofilms produced in our biofilm
system are clearly not generated in this way. Rather, they are formed after the mass
exodus of the bulk of the early biofilm, and appear to arise as a result of the rapid growth
of only a few remaining cells. In the absence of staphylococcal nuclease, these tower
structures are not observed, either because they are overwhelmed by the presence of
an unusually robust accumulation of biomass, or because a key developmental switch
fails to trigger. Continued studies are required to provide a greater understanding of
these fascinating developmental processes, as well as the functions of the structures
that are formed.
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CHAPTER IV: 5
Correlation of cell death/extracellular DNA and expression of the cidABC and
lrgAB operons during Staphylococcus aureus biofilm development

INTRODUCTION
The primary focus of our laboratory has been the characterization of two S.
aureus operons, cidABC and lrgAB, and their roles in programmed cell death (PCD) and
biofilm development. Although the exact mechanisms have yet to be elucidated,
previous studies of planktonic cultures have shown that the cid and lrg operons respond
to alterations in carbon overflow (overflow metabolism) (217) (218) (219). Although not
completely understood, overflow metabolism (i.e. conditions of excess glucose and
oxygen) is a phenomenon in which carbon flow into the TCA cycle is limited by carbon
catabolite repression (220) (221) (222) (223). Thus, carbon is redirected into various
pathways including the Pta/AckA and AlsS/AlsD pathways, accumulating extracellular
acetate and acetoin, respectively, and consuming intracellular pyruvate (224).
Interestingly, CidR, the LysR-type transcriptional regulator (LTTR) that induces coexpression of cidABC and alsSD operons, is known to be induced by high
concentrations of acetate under conditions of carbon overflow (i.e. 35 mM glucose) (217)
(217) (219).

Intriguingly, the cidC and alsSD genes are known to encode three

metabolic enzymes, specifically involved in overflow metabolism: pyruvate oxidase
(CidC), acetolactate synthase (AlsS), and acetolactate decarboxylase (AlsD), that have
also recently been shown to play additional opposing roles in PCD and biofilm
development (219). Opposing the cid operon in PCD, the lrgAB operon is regulated by

The majority of the work in CHAPTER IV has been published in Moormeier DE,
Endres JL, Mann EE, Sadykov MR, Horswill AR, Rice KC, Fey PD, Bayles KW.
AEM. 2013.
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LytSR, a two-component regulatory system (TCRS) (225) (174). LytSR is known to
induce lrgAB expression by sensing changes in membrane potential, as demonstrated
using

membrane-dissipating

agents,

such

as

carbonyl

cyanide

m-

chlorophenylhydrazone (CCCP) and gramicidin, altering cell death and lysis and leading
to biofilm modulations and decreased biofilm adherence (226). Additionally, it has been
shown that, under conditions of overflow metabolism, that lrgAB is induced in a LytSRdependent manner, coinciding with extracellular acetate accumulation (217). In addition,
our results also demonstrate that lrg expression can also be induced in a LytSindependent manner as a result of increased levels of acetyl-phosphate, an overflow
intermediate metabolite, which acts as a phoshodonor to phosphorylate LytR (227) (228)
(229) (230).
Collectively, these data suggest that the cid and lrg operons respond to
alterations of central metabolism, which are dependent on the conditions of the
surrounding environments including oxygen levels, glucose levels, and pH. However,
modulations of central metabolism and their roles in biofilm development have yet to be
completely illuminated. Thus, the studies described in this chapter were designed to
assess the metabolic heterogeneity of developing biofilm microenvironments and the
roles they play in the differential expression the cid and lrg operons.

RESULTS
Induction of cid and lrg expression during hypoxic growth
Previous studies of cidABC and lrgAB transcription showed that expression of
both of these operons was induced during aerobic overflow metabolism (143) where the
high rate of glycolysis inhibits aerobic respiration and induces carbon flow through
fermentation pathways (231). Since staphylococcal biofilms contain regions of hypoxia
(142), we hypothesized that the decrease in oxygen concentrations, leading to activation
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of fermentative metabolism, will also affect cid and lrg expression. To test this, RNA was
extracted from aerobically- and hypoxically-grown cells at 4 hr post inoculation and the
relative levels of cid- and/or lrg-transcripts were determined using quantitative reverse
transcriptase PCR (qRT-PCR). Measurements of oxygen revealed that hypoxic growth
resulted in an oxygen concentration of approximately 1% total saturation, compared to
approximately 70% total oxygen saturation under our standard growth conditions (see
Chapter II). As anticipated, the levels of the cid-specific transcripts were markedly
increased (approximately 12 fold) in cells grown under hypoxic conditions compared to
cells grown aerobically (Figure 4-1A). Consistent with previous studies (145), cid
expression was induced under excess glucose conditions in a cidR-dependent but
lytSR-independent manner, respectively (data not shown). Similarly, the induction of cid
expression under hypoxic conditions was found to be cidR dependent and lytSR
independent (Figure 4-1A). In contrast, lrgAB transcription was found to be slightly
decreased under hypoxic conditions, but remained lytSR dependent (Figure 4-1B) as
previously demonstrated (159, 232). Additionally, we found that lrgAB expression was
not influenced by the cidR mutation during growth under hypoxic conditions (Figure 41B). Taken together, these data demonstrate that hypoxic conditions induce cidABC
operon expression in a CidR-dependent manner, similar to its induction observed during
overflow metabolism. However, unlike the induction of lrgAB expression previously
observed during overflow metabolism, hypoxic growth does not affect lrgAB
transcription.

Expression of cid and lrg in individual cells
To test the hypothesis that the cid and lrg operons are differentially expressed
within a growing biofilm, we generated cid and lrg transcriptional reporter fusions to
facilitate the assessment of expression of these genes in individual cells during different
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Figure 4-1 Hypoxic induction of cidABC and lrgAB transcription
Total
RNAs
were
collected
from S.
aureus WT
(UAMS-1), cidR mutant,
and lytSR mutant cells at 4 h of growth under aerobic and hypoxic conditions.
The cidABC (A) and lrgAB (B) transcripts present in the RNA were detected by qRTPCR with cidA- and lrgA-specific primers, normalized to the levels of sigA-specific
transcripts detected, and then plotted as n-fold changes relative to the cidABC and lrgAB
transcript levels in WT cells grown under aerobic conditions. Error bars represent
standard deviations generated from three independent experiments. In panel A,
significant differences (P < 0.05 for all) between aerobic and hypoxic treatments are
denoted as follows: *, WT; **, ΔlytSR. In panel B, significant differences (P < 0.05 for all)
between aerobic and hypoxic treatments are denoted as follows: *, WT; **, ΔcidR.
Figure modified from Moormeier et al. 2013. AEM
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stages of biofilm development. Promoter regions of both the cid or lrg operons were
amplified and inserted upstream of the gene encoding super-folder GFP (sGFP),
previously shown to be easily detected in S. aureus cultures (160). The resulting
constructs were moved into UAMS-1, as well as the cidR and lytSR derivatives of this
clinical isolate. The strains were tested to determine if GFP expression during planktonic
growth reflected the transcriptional regulation seen by Northern blot analyses (143, 145,
232) and using qRT-PCR analyses (Figure 4-1). Indeed, when grown in the presence of
excess glucose or under hypoxic conditions, the Pcid::gfp reporter construct produced
increased levels of GFP fluorescence (Figure 4-2), as opposed to aerobically grown cells
in the absence of glucose, and was cidR-dependent (Figure 4-2). In contrast, the
Plrg::gfp promoter construct did not produce detectable fluorescence under these
conditions (Figure 4-2). However, when grown in the presence of CCCP, a membrane
potential dissipating agent known to induce lrgAB expression, the Plrg::gfp promoter
construct fluoresced brightly in a lytSR-dependent manner (Figure 4-3). As a control, we
also generated a gfp fusion to the ldh1 promoter that is specifically expressed during
hypoxic growth (233). In wild type cultures containing the Pldh1::gfp promoter fusion
grown in hypoxic conditions, GFP fluorescence was seen in the majority of cells as
compared to the absence of fluorescence in cells grown aerobically in the presence or
absence of excess glucose (Figure 4-2).

Expression of cid and lrg operons during biofilm development
To study cid and lrg expression within a biofilm, we first examined the fluorescent
reporter constructs in biofilm grown under static conditions. As shown in Figure 4-4
(panels A and C), GFP fluorescence was observed in biofilm formed by the wild-type
strain containing the cid fusion, but not in the cidR mutant, similar to growth under
planktonic conditions (Figure 4-1). Also similar to planktonic growth (Figure 4-2), the
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Figure 4-2 Expression of fluorescent reporters during planktonic growth
S. aureus UAMS-1 (185), the cidR mutant (ΔcidR) strain, and the lytSR mutant (ΔlytSR)
strain containing the Pcid::gfp, Plrg::gfp, and Pldh::gfp transcriptional reporter plasmids
were grown to exponential phase in the presence or absence of 35 mM glucose and
under aerobic and hypoxic conditions as indicated. GFP-positive cells were visualized by
CLSM at ×630 magnification as described in Materials and Methods. The scale bar
represents 5 μm.
Figure modified from Moormeier et al. 2013. AEM
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Figure 4-3 CCCP induction of lrgAB promoter activity
S. aureus UAMS-1 (panels A and B) and its lytS mutant derivative, KB999 (panels C and
D), each containing the Plrg::gfp promoter fusion plasmid, were grown to midexponential phase and treated with CCCP, a depolarizing agent previously shown to
induce lrgAB transcription. GFP positive cells were visualized by confocal laser scanning
microscopy as described in Materials and Methods. Scale bar represents 5 µm.
Figure modified from Moormeier et al. 2013. AEM
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lrgAB promoter was not expressed in a static biofilm (Figure 4-4D). As anticipated
based on previously published results demonstrating the hypoxic nature of static biofilms
(142), the ldh1 promoter fusion construct also expressed GFP fluorescence in our static
biofilm assays (Figure 4-4B).
To examine the pattern of cid and lrg expression during biofilm development
under flow cell conditions, we took advantage of BioFlux1000 technology (147) to
acquire sequential bright-field and epifluorescence images of a developing biofilm.
Analysis of the epifluorescent images revealed distinct patterns of cid and lrg expression
during the development of these biofilms. Using the UAMS-1 Pcid::gfp fusion strain
(Figure 4-5), distinct clusters of cells or “towers” emerged and gradually turned green as
they increased in size, similar to the pattern of expression observed with the Pldh1::gfp
fusion strain (Figure 4-6), consistent with the hypothesis that hypoxic regions of the
biofilm (within the interior of the large towers) induce cid expression. Unexpectedly, the
Pcid::gfp fusion strain also produced smaller towers with constitutively high levels of
fluorescence (Figure 4-7), clearly distinct from the larger towers. These smaller towers
appear to emerge from a single highly fluorescent cell that divides (although with a
seemingly slower growth rate compared to the other clusters) and remains exclusively
associated with its siblings until a large, intensely fluorescent tower was formed. In
addition, these towers appeared to be less adherent, as demonstrated by their
propensity to release smaller cell clusters (Figure 4-7). Importantly, similar highly
fluorescent towers were observed using the Pldh1::gfp fusion strain (Figure 4-8),
suggesting that overlapping metabolic cues may be responsible for high level cid and
ldh1 expression observed in these small towers. Also, no Pcid::gfp-mediated
fluorescence in either tower type was observed in a strain in which the cidR gene had
been disrupted (data not shown), suggesting that the signals responsible for cid
expression in both tower types were similar.
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Figure 4-4 Analysis of cid and lrg expression during static biofilm growth
S. aureus UAMS-1 cells containing: (A) Pcid::gfp promoter fusion in UAMS-1 [UAMS-1
(pEM81)], (B) Pldh1::gfp promoter fusion in UAMS-1 [UAMS-1 (pEM87)], (C) Pcid::gfp
promoter fusion in the cidR mutant [KB1090 (pEM81)], and (D) Plrg::gfp promoter fusion
in UAMS-1 [UAMS-1 (pEM80)]. Three-dimensional images of the biofilms were
generated using confocal laser scanning microscopy as described in the Materials and
Methods. Images are representative of three independent experiments. Scale bar
represents 40 µm.
Figure modified from Moormeier et al. 2013. AEM
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Figure 4-5 Temporal analysis of cidABC expression during biofilm development
S. aureus cells containing the Pcid::gfp reporter plasmid were inoculated into a BioFlux
microfluidic system and allowed to form a biofilm within a flow shear environment at a
flow rate of 64 μl/h for a total of 18 h. Bright-field and epifluorescence microscopic
images were collected at 5-min intervals. The images presented were taken from the
complete set of 217 images taken at ×200 magnification, spanning 9 to 14.5 h, and
illustrate typical tower development and GFP expression observed in multiple
experiments. The scale bar represents 50 μm.
Figure modified from Moormeier et al. 2013. AEM
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Figure 4-6 Temporal analysis of ldh1 expression during biofilm development
S. aureus cells containing the Pldh1::gfp reporter plasmid were inoculated into a BioFlux
microfluidics system and allowed to form a biofilm within a flow-shear environment at a
flow rate of 64 µl/h for a total of 18 h. Bright-field and epifluorescence microscopic
images were collected at 5-min intervals using 200× magnification. The images
presented were taken from the complete set of 217 images spanning 12.5-18 h and
illustrate typical tower development and GFP expression observed in multiple
experiments. Scale bar represents 50 µm.
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Figure 4-7 High-level cid expression in small towers during biofilm formation
S. aureus cells containing the Pcid::gfp reporter plasmid were inoculated into a BioFlux
microfluidic system and allowed to form a biofilm as described in the legend to Figure 45. The image shown (at ×200 magnification) represents a typical constitutive highly
fluorescent “small” tower that is formed by this strain, distinct from the delayed
fluorescence produced by the “large” towers depicted in Figure 4-5. Note the presence
of detached, highly fluorescent cells “downstream” (to the right) of the tower. The scale
bar represents 50 μm.
Figure modified from Moormeier et al. 2013. AEM
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Figure 4-8 High-level ldh1 expression in small towers during biofilm formation
S. aureus cells containing the Pldh1::gfp reporter plasmid were inoculated into a BioFlux
microfluidic system and allowed to form a biofilm as described in the legend to Figure 45. The image shown (at ×200 magnification) represents a typical constitutive highly
fluorescent “small” tower that is formed by this strain, distinct from the delayed
fluorescence produced by the “large” towers depicted in Figure 4-6. Note the presence
of detached, highly fluorescent cells “downstream” (to the right) of the tower.
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The UAMS-1 Plrg::gfp fusion strain exhibited a different pattern of expression
during biofilm development (Figure 4-9). Similar to the cid and ldh1 promoter fusion
constructs, the Plrg::gfp fusion strain produced fluorescence in what appeared to be the
large towers that exhibited inducible cid and ldh1 expression as the towers matured.
However, unlike what was observed with the cid and ldh1 promoter fusion constructs,
the Plrg::gfp fusion strain produced constitutive fluorescence without increasing
expression within growing towers, consistent with results indicating that this promoter is
not inducible under hypoxic conditions. Importantly, it should be noted that despite the
fact that the Plrg::gfp fusion strain did not produce detectable fluorescence in planktonic
culture or static biofilm assays, this strain produced robust fluorescence within towers
formed in this flow-cell system suggesting that this operon is controlled by
developmental signals associated with biofilm formation. As expected, the fluorescence
produced by the Plrg::gfp construct was abolished in a lytSR mutant background (101).
To clearly distinguish the coincidence of cid and lrg expression within the tower
structures, a dual cid/lrg reporter strain was also generated. The cid promoter was fused
to the gene encoding sGFP, and the lrg promoter was fused to the gene encoding
DsRed.T3 (DNT). Wild-type UAMS-1 containing this construct was grown using the
BioFlux system and observed during biofilm development. As shown in Figure 4-10, lrg
expression (red fluorescence) was detected early in the development of the towers (12
h) followed by the emergence of cid expression (green fluorescence) as the towers
increased in size (starting at 16 h). Distinct small towers expressing high levels of cid
were also observed (arrows), similar to those produced by the Pcid::gfp fusion strain
(Figure 4-6). As shown in Figure 4-11, which illustrates the fluorescence detected using
the different filter sets, the small towers clearly express a high level of cid-associated
sGFP

fluorescence

and

nearly

undetectable

levels

of

lrg-associated

DsRed

fluorescence, while the large towers express both promoters, albeit in different temporal
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Figure 4-9 Temporal analysis of lrgAB expression during biofilm development
S. aureus cells containing the Plrg::gfp reporter plasmid were inoculated into a BioFlux
microfluidic system and allowed to form a biofilm within a flow shear environment at a
flow rate of 64 μl/h for a total of 18 h. Bright-field and epifluorescence microscopic
images were collected at 5-min intervals at ×200 magnification. The images presented
were taken from the complete set of 217 images spanning 9 to 14.5 h and illustrate
typical tower development and GFP expression observed in multiple experiments. The
scale bar represents 50 μm.
Figure modified from Moormeier et al. 2013. AEM
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Figure 4-10 Simultaneous temporal analyses of cidABC and lrgAB expression
during biofilm development
S. aureus cells containing the Pcid::gfp and Plrg::sDsRed dual-reporter plasmid were
inoculated into a BioFlux microfluidic system and allowed to form a biofilm within a flow
shear environment at a flow rate of 64 μl/h for a total of 18 h. Bright-field and
epifluorescence microscopic images were collected at 5-min intervals at ×200
magnification. The images presented were taken from the complete set of 217 images
spanning 12 to 17.5 h and illustrate the typical tower development and GFP and
DsRed.T3(DNT) expression observed in multiple experiments. The scale bar represents
50 μm. The arrows indicate the small, highly fluorescent cid-expressing towers.
Figure modified from Moormeier et al. 2013. AEM
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Figure 4-11 Differential expression of cid and lrg within different towers
The individual images collected at 17 h from Figure 4-10 are presented to better
illustrate the green and red fluorescence produced by the S. aureus Pcid::gfp and
Plrg::sDsReddual-reporter strain (at ×200 magnification). The panels include images
collected by bright-field microscopy only (A), a bright-field microscopy and FITC overlay
(B), a bright-field microscopy and TRITC overlay (C), and a bright-field microscopy,
FITC, and TRITC overlay (D). The scale bar represents 50 μm. The arrows indicate the
small, highly fluorescent cid-expressing towers.
Figure modified from Moormeier et al. 2013. AEM
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patterns. These data confirm the existence of two distinct towers types, one that is
characterized by rapid cell division, constitutive lrg expression, and gradual cid
expression induced presumably as the tower enlarges and becomes hypoxic, and the
other that exhibits relatively slow cell division and high, constitutive levels of cid
expression.

Correlation of lrg expression with cell death and lysis
Previous studies using confocal laser scanning microscopy demonstrated that
tower structures contain a high number of dead cells and/or eDNA as indicated using
viability staining techniques (100). Subsequent lysis of the dead cells resulted in clear,
cell-free voids that likely contain cell debris, including released genomic DNA. This
pattern of death and lysis causing a “hollowing out” of tower structures appears to be
conserved in other bacterial species (138, 234), including a positive role for P.
aeruginosa cid and a negative role of lrg orthologs in this process (138). To determine if
cid and/or lrg expression correlated with cell death and lysis under these flow-cell
conditions, we grew our Pcid::gfp and Plrg::gfp fusion constructs in the BioFlux system
and stained the biofilm with propidium iodide (PI) to visualize dead cells and eDNA. As
shown in Figure 4-11, the large towers expressing both cid and lrg were readily stained
with PI, exhibiting a relatively uniform fluorescence intensity throughout these structures
(see top and bottom panels), similar to the uniform GFP-mediated fluorescence
produced by the Plrg::gfp fusion construct. Analysis of the temporal pattern of PI staining
also corresponded well with lrg expression with staining of the tower occurring early in
development and continuing as they grew in size. This is in contrast to the Pcid::gfp
reporter construct, which is expressed in the center of the tower structures only after
they have reached a certain size, presumably corresponding to the hypoxic regions of
the towers (see above). Interestingly, the smaller, intensely fluorescent green towers that
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Figure 4-12 Correlation of eDNA/cell death with cidABC and lrgAB expression
within a biofilm
S. aureus WT cells carrying the Pcid::gfp and Plrg::gfp reporter plasmids were
inoculated into a BioFlux microfluidic system and grown into biofilms as described in the
legend to Figure 4-5. The biofilm was grown in 50% TSB medium containing 0.125 μM
PI stain (184) to stain dead cells and eDNA. Individual images captured at 17 h
demonstrate an overlap of lrg expression (green) and dead cells/eDNA (184) in large
towers (top and bottom panels) and the absence of lrg expression and dead cells/eDNA
in small towers (middle panels). The scale bar represents 50 μm.
Figure modified from Moormeier et al. 2013. AEM.
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constitutively express the cid promoter (Figure 4-12; middle panels) did not retain the PI
stain, also similar to the absence of expression observed in these structures (Figures 410 and 4-11). Overall, the results of these studies demonstrate an association with the
patterns of cid and lrg expression within a developing biofilm corresponds with the
presence of dead cells and/or eDNA in tower structures.

Mutations in Pta-AckA pathway increase highly-constitutive cid expressing small
towers during biofilm development
Given the intimate relationship with overflow metabolic pathways and the
changes in expression of the cidABC and lrgAB operons, we wanted to determine the
effects that mutations in different metabolic pathways had on expression of the cid and
lrg

operons

as

wells

as

biofilm

morphology.

Recently,

inactivation

of

the

phosphotransacetylase-acetate kinase (Pta-AckA) pathway has been demonstrated to
increase cell death and increased expression of the CidR regulon, which includes
cidABC (154). Therefore, we moved our dual cid and lrg reporter plasmid (pDM4) into
∆ackA::ermB and ∆pta mutants and evaluated cid and lrg expression as well as biofilm
morphologies. Strikingly, the ∆ackA::ermB and ∆pta mutants demonstrated increased
cidABC expression, as well as an increased number of what appear to be the small high
cid-expressing towers observed in the wild-type strain (Figure 4-13). Additionally, no lrg
expression was observed in either mutant strain (Figure 4-13), in contrast to what was
previously observed in these mutants grown planktonically (101). Together, these results
demonstrate an intimate relationship between metabolic pathways and the expression of
the cid and lrg operons and the changes that can occur during tower development in the
later stages of biofilm development.
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Figure 4-13 High-level cid expression and increased small towers in ackA and pta
mutants during small formation
S. aureus mutants ∆ackA::ermB and ∆pta cells containing the Pcid::gfp reporter plasmid
were inoculated into a BioFlux microfluidic system and allowed to form a biofilm as
described in the legend to Figure 4-5. The image shown (at ×200 magnification)
represents a typical constitutive highly fluorescent “small” tower that is formed by this
strain. The scale bar represents 50 μm.
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DISCUSSION

Previous studies in our laboratory have suggested a role for S. aureus cid- and
lrg-mediated cell death and lysis during biofilm development (99, 100). Implicit in this
model is that there is heterogeneity in the expression of these operons such that only
subpopulations of the biofilm cells will die and lyse. Indeed, viability stains clearly
revealed marked heterogeneity in the distribution of dead cells within the basal biofilm
layers, and more pronounced cell death and lysis associated with tower structures (100).
Although these observations suggest that variations in cid and lrg expression may exist
within different regions of a biofilm, our current understanding of cid and lrg regulation
has been limited to studies in which the expression of these operons was assessed
during planktonic growth, where the results generated represent an average level of
expression throughout the population. For example, glucose metabolism in planktonic
cultures was shown to induce cidABC expression via the LysR-type transcriptional
regulator (LTTR) encoded by the cidR gene (143-145). Additionally, the two-component
regulatory system, LytSR, was shown to induce lrgAB transcription in response to
changes in membrane potential (146, 159). Although both of these studies provided an
appreciation for the metabolic signals important in the control of cid and lrg expression,
neither afforded any insight into the heterogeneity of gene expression within the
population nor how expression of these operons might be affected by growth in the
context of a multicellular biofilm. Thus, a key focus of this study is to gain a better
understanding of how these and/or related metabolic signals are involved in coordinating
cid and lrg expression during biofilm development.
In the first part of this study, we demonstrate that in addition to being induced by
growth in the presence of excess glucose, cid expression is also induced during growth
in a hypoxic environment (Figure 4-1), conditions known to predominate within a biofilm.
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In fact, aerobic growth in the presence of excess glucose is well-known to induce a
physiological change in cells that results in a shift from oxidative phosphorylation to
substrate-level phosphorylation in which less oxygen is consumed (235). This so-called
“Crabtree effect” may, thus, produce metabolic intermediates during aerobic growth that
stimulate CidR-dependent expression of the cid operon that would normally be produced
during hypoxic growth. In agreement with the notion that similar metabolic signals are
sensed during these seemingly disparate conditions is the observation that cid
expression under hypoxic conditions was found to be cidR dependent, similar to the
induction of this operon during growth in the presence of excess glucose (Figure 4-1). As
cidR encodes a member of the LysR-type transcription regulator (LTTR) family of
proteins, whose members are activated by the binding of specific small effector
molecules, the effector interacting with CidR likely reflects the metabolic similarities that
form the basis of the Crabtree effect. Although the identity of this molecule remains to be
determined, it was recently speculated that pyruvate or an intermediate of pyruvate
metabolism could serve this purpose based on the observations that CidR-mediated
control occurs under conditions favoring fermentative metabolism, as well as the fact
that the CidR regulon includes two operons, both of which encode enzymes involved in
pyruvate metabolism (231). Interestingly, recent studies indicate that pyruvate plays a
key role in the formation of microcolonies in Pseudomonas aeruginosa (236).
It seems clear that the expression and/or function of the cid and lrg operons must
be a population-dependent phenomenon, given the observation that there is a mixture of
live and dead cells within biofilms. Because cell death and lysis are particularly
predominant within tower structures (100), we hypothesized that the level of cid
expression relative to lrg is increased in tower structures compared to the surrounding
basal layer of cells (123). The differences in expression may be a function of localized
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microenvironments in which reduced oxygen is present. Indeed, oxygen and nutrient
gradients have been shown to exist in biofilm and have been implicated in signaling
heterogeneity within the biofilm (142, 237, 238). Furthermore, P. aeruginosa (239, 240)
and B. subtilis (241-243) demonstrate heterogeneous expression of genes within the
biofilms they produce. Based on the impact of hypoxic growth on cid and lrg expression,
we reasoned that variations in oxygen levels within a biofilm play an important role in the
differential control of cid and lrg expression, and subsequent cell death and lysis within
these metabolically diverse communities. Thus, to examine the differential control of cid
and lrg expression during biofilm development, transcriptional fusions of cid and lrg
promoter regions with a gfp reporter gene were generated and introduced into S. aureus
wild-type, cidR, and lytSR mutant strains. We took advantage of newly developed
BioFlux technology (147) that allowed us to simultaneously monitor biofilm growth and
reporter gene expression under flow-cell conditions over an extended time-course
experiment, mimicking a more physiologically relevant environment. Strikingly, growth of
the cid and lrg reporter strains revealed clear temporal and spatial control of these
genes. For the cid::gfp strain, fluorescence increased over time in large tower structures
(Figure 4-5 and Figure 4-10), similar to the ldh::gfp strain (Figure 4-6) and consistent
with the hypothesis that reduced oxygen levels within these structures was responsible
for the up-regulation of these genes. In addition, a second highly fluorescent
subpopulation of cells was observed in the cid::gfp fusion strain that was clearly distinct
from those associated with large tower structures (Figures 4-7, 4-10, and 4-11). In
contrast to the latter, the highly fluorescent subpopulation appeared to emerge from
single cells that multiplied and formed distinct tower structures that appeared less
adherent as evidenced by the observation that they tended to release small cell clusters
likely as a result of shear forces in this flow-cell environment (Figure 4-7). Thus, the
differences in gene expression observed between the two tower types identified in this
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study appear to be associated with fundamentally distinct physical characteristics, such
as matrix composition, although this remains to be investigated. Importantly, the lack of
a genetically stable highly fluorescent population of cells within the effluent (data not
shown) suggests these highly fluorescent towers are not a result of a regulatory mutation
(e.g. - within the cidR gene).
The lrgAB::gfp strain also generated a fluorescent signal that was associated
with tower structures (Figure 4-9). Although the kinetics of this induction were clearly
distinct compared to the delayed, gradual emergence of fluorescence observed in the
large towers produced by the Pcid::gfp and Pldh1::gfp fusion strains, it was similar in
some respects to the small towers expressing high levels of GFP fluorescence.
However, a dual reporter construct allowed us to determine the relationship between cid
and lrg expression within individual towers and clearly demonstrated that towers
exhibiting a gradual increase in cid expression were also constitutively expressing lrg. In
contrast, towers expressing constitutively high cid levels were expressing low to
undetectable levels of lrg. The differences in cid and lrg expression undoubtedly reflect
the fact that expression of these operons is controlled by distinct regulatory systems that
respond to different metabolic signals. Thus, gaining a better appreciation for the
metabolic cues sensed by the CidR and LytSR regulatory systems, as well as the
metabolic differences between these tower types, will be essential for understanding the
basis for the expression differences observed.
Given the proposed functions of the cid and lrg operons, we next wanted to
examine the correlation between expression of these genes in a biofilm, and the death
and lysis that occurs in these structures. As shown in Figure 4-12, analyses of the cid
reporter construct revealed that the GFP signal produced by the cid::gfp strain
overlapped with the PI staining, which was previously shown to be particularly evident in
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these structures (100). However, it is clear that this overlap is incomplete as evidenced
by the observation that the high-level expression observed in the smaller towers was not
associated with PI staining (Figure 4-12, middle row panels). In contrast, fluorescence
produced by the lrg::gfp strain correlated much better with the PI-stained structures
(Figure 4-12, bottom row panels) exhibiting homogeneous fluorescence throughout the
large towers and no fluorescence in the small towers. Since the cidA and lrgA gene
products are proposed effectors of cell death and lysis, one might predict that the
disruption of these genes would affect the death and/or lysis observed by PI staining.
However, similar experiments using cid and lrg mutants harboring the cid and lrg GFP
reporter constructs revealed no obvious effect on the pattern of cell death and lysis (as
indicated by PI staining; data not shown), suggesting that the roles of these genes are
not readily detectable under these conditions. One scenario is that the Cid and Lrg
proteins encoded by these operons simply potentiate cell death and under biofilm
conditions makes this process more efficient. In fact, holin proteins function much like
this as they are expressed and inserted in the membrane in an inactive form and can be
induced by lethal agents that dissipate the membrane potential (244). Similarly, altered
expression of members of the Bcl-2 family of proteins, critical in the control of apoptosis,
does not directly affect cell viability but instead, potentiates cell death or survival
depending on the relative levels of death effectors or inhibitors that are present in the
cell (245). Another hypothesis is that this BioFlux1000 system uses two-dimensional
image acquisition software and microfluidic flow-cell conditions. These capabilities may
not have the sensitivity to evaluate slight changes in biofilm morphology like previously
described flow-cell biofilms that have taken advantage of confocal scanning laser
microscopy to render three-dimensional images and quantify subtle changes using
sophisticated biofilm quantification software called COMSTAT (246).
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Given the apparent fundamental differences in gene expression and physical
properties of large versus small towers, a better understanding of the relative
physiological differences between these tower types should provide valuable information
about the control of cell death during biofilm development. Furthermore, insight into the
potential functional differences that are associated with spatially and temporally
regulated genes within the biofilm, as has been observed in Bacillus subtilis (247), could
be particularly enlightening. Thus, current studies using Bioflux technology are aimed at
using fluorescent metabolic probes that will allow us to correlate the temporal and spatial
aspects of cid and lrg expression with differential physiological states within biofilm
microenvironments, providing more mechanistic and functional insights into the
heterogeneous control of cell death and lysis observed within a developing biofilm.
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CHAPTER V:
CONCLUSIONS AND FUTURE DIRECTIONS

In this dissertation, we have developed a model of S. aureus biofilm development
using the BioFlux1000 microfluidic device that is described in five sequential stages: 1.
attachment, 2. multiplication, 3. exodus, 4. tower maturation, and 5. dispersal (Figure 51). More specifically, S. aureus biofilms cells first attach to the bottom of the glass
bottom plates (Figure 5-1A). Then, as fresh media is perfused across attached cells, the
biofilm develops into a confluent ‘mat’ of cells (multiplication) (Figure 5-1B). Upon
reaching confluency, a period of mass exodus of cells occurs in which a subpopulation
of cells is released from the biofilm (Figure 5-1C) allowing the formation of distinct threedimensional structures. These structures, designated as towers, form from distinct foci of
cells that rapidly divide to form robust aggregations (Figure 5-1D). It is at this point that
portions of the tower begin to disperse to start the process again (Figure 5-1E).

Attachment and Multiplication
During the attachment and multiplication stages, we discovered under these flowcell conditions that this phase appears to rely primarily on proteins, rather than eDNA or
PIA, given that the initial stages of development are susceptible to proteinase K
treatment. In addition, we also discovered that proteins such as AtlA and δ-toxin
potentially interact with the glass surface of the BioFlux plate presumably through charge
interactions. Additionally, by screening the Nebraska Transposon Mutant Library, we
found that most LPXTG-motif containing proteins and MSCRAMM proteins appeared to
not have a major role during the initial stages. However, it cannot be ruled out
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Figure 5-1 Working model of Staphylococcus aureus biofilm development in
BioFlux1000
S. aureus biofilm development using the BioFlux1000 microfluidic device is described in
five stages: 1. attachment, 2. multiplication, 3. exodus, 4. tower maturation, and 5.
dispersal. (Figure 5-1A; Attachment) S. aureus biofilms cells first attach to the bottom of
the glass bottom plates. (Figure 5-1B; Multiplication) As fresh media is perfused across
attached cells, the biofilm develops into a confluent ‘mat’ of cells. (Figure 5-1C; Exodus)
Upon reaching confluency, a period of mass exodus of cells occurs in which a
subpopulation of cells is released from the biofilm allowing the formation of distinct threedimensional structures. (Figure 5-1D; Tower Maturation) These structures, designated
as towers, form from distinct foci of cells that rapidly divide to form robust aggregations.
(Figure 5-1E; Dispersal) It is at this point that portions of the tower begin to disperse to
start the process again.
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that there may be involvement of more than one of these proteins, and that disruption of
a single gene encoding one of these proteins may not cause a large enough defect to
see any changes in biofilm development.
To continue to determine the functions that the AtlA protein has during biofilm
development, a more detailed approach must be taken. Given that AtlA is the major
autolysin of S. aureus, we cannot rule out that the fact that a defect in this protein will
generate cells with a defective cell wall that could lead to drastic effects on the
placement of extracellular proteins of the cell surface or in a developing biofilm.
Therefore, further genetic approaches using point mutations aimed at dissecting the
enzymatic activity in conjunction with extracellular protein profiling of these may provide
results that can determine whether or not a defective AtlA is disrupting proper
extracellular protein placement. In addition to processing the cell wall of S. aureus, the
glucosaminidase domain of AtlA has also been shown to bind DNA suggesting that there
may be a potential eDNA-protein interaction that is occurring within the biofilm matrix.
Hence, using DNA-specific stains and/or antibodies in combination with genetic
mutations of the DNA-binding domain may aid in determining the effects that AtlA has a
possible eDNA-binding protein. Lastly, AtlA also serves as a mediator of lysis and eDNA
release during biofilm development. In order to better understand this process, genetic
mutations disrupting functional enzymatic activity may provide immense information on
how this process is occurring.
The PSMs including δ-toxin are well-characterized in their functions in S. aureus
biofilm development. Nonetheless, to determine if there is a direct function of δ-toxin
under our biofilm conditions, either a δ-toxin mutant must be obtained or constructed and
then evaluated for biofilm development in the BioFlux1000. One complicating issue with
studying the δ-toxin is that the hld gene resides within the RNAIII-transcript (116).
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Therefore, a mutant with a generated translational termination site that does not interfere
with the RNAIII transcript would need to be generated. Based, on previous reports
evaluating the role of δ-toxin and the other PSMS in biofilm development (117), we
hypothesize that we would see robust biofilm growth after the exodus stage in a δ-toxin
mutant when compared to wild-type.
In addition to the large contribution of extracellular proteins to the biofilm ECM
during the attachment and multiplication stages, there also appears to be a contribution
of eDNA, given that a defective nuclease causes abrogation of the exodus event. As
discussed before, there may be eDNA-protein interactions that act as scaffold for the
biofilm matrix. One particularly interesting group of eDNA-binding proteins are the
nucleoid- associated proteins ( NAPs) which have been shown to have a function in the
ECM of staphylococcal biofilms (107). To determine if NAPs indeed have function in
biofilm scaffolding, the first thought would be to construct a mutation in the gene
encoding the NAP protein. However, this is impossible because the protein is essential
to S. aureus survival (193). An additional factor that may complicate studying this protein
is that disruption of a gene that is important for chromosomal condensation may have
drastic effects on global regulation within the cell and not solely on eDNA-protein
interactions in the biofilm ECM. Thus, non-mutational microscopy approaches utilizing
eDNA specific stains and/or antibodies in conjunction with NAP-specific antibodies are
currently being conducted to determine if there are NAP-eDNA interactions contributing
to the ECM within the multiplication stage.
One major complicating issue that often causes disagreement between
investigators on which molecular determinants are important for biofilm development is
that researchers use varying degrees of biofilm conditions including different types of
media, shear stresses, and plasma coating. Therefore, to continue to determine the
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potential functions that some of these previously described proteins have in biofilm
development, we must test our mutants in several experimental conditions. One simple
experimental condition to change would be to coat the microfluidic channels of the
BioFlux with host substrates that are found in human plasma rather than allowing the
cells to adhere directly to the glass bottom of the BioFlux plate. This has already been
performed in a recent study where the S. aureus cells were allowed to adhere to human
plasma. Under these conditions, the authors discovered that saeRS mutants actually
generated less overall biofilm development when compared to their respective UAMS-1
and JE2 wild-types even under similar shear stress conditions (42). This is directly
opposing to what was discovered in our studies in this dissertation. Thus, the mutants
used throughout in this dissertation must also be examined under various experimental
biofilm conditions to determine if their functions are dependent on other biological
conditions.

Exodus
The exodus stage is an early biofilm dispersal stages that precedes the
maturation of tower structures. It was first described in these studies and was named
this to delineate between the Agr-mediated dispersal events that have been described
vigorously in the literature. While exodus was first described in these studies, in the past,
there have been several reports describing that S. aureus produces nucleases that
modulate biofilm development by degrading eDNA within the ECM. However, none of
these previous studies provided as much detail into the timing and regulation. As
described in these studies, exodus is clearly mediated by the degradation of eDNA by
the secreted nuclease, and is tightly regulated by the multi-component Sae system.
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Indeed, the Sae system regulates the exodus process so tightly that only a
subpopulation of cells expresses nuclease. In further support of this, the subpopulation
of cells becomes highly dysregulated when genes within the sae operon begin to be
mutated.
One question is why does disruption of the gene encoding the SaeP protein
cause every cell within the biofilm to express nuclease and other Sae-regulated factors?
As previously discussed, this may be because deletion of SaeP cannot form a complex
with SaeQ to activate the phosphatase activity of SaeS causing the cells to lack a
mediator of self-control in SaeS phosphorylation, and uncontrolled transcription levels of
Sae-regulated factors. Another thought is that the SaeP protein located on the surface of
the subpopulation of cells is binding eDNA within the ECM, and thus, unable to interact
with SaeQ to repress transcription of Sae-regulated genes. This makes sense
considering when saeP is deleted all of the cells in the biofilm transcribe the gene
encoding nuclease and staphylocoagulase. From these data, it’s obvious that the next
steps are to determine the eDNA-binding sites in SaeP, and then genetically mutate
these sites and determine the effect on nuclease expression in both biofilm and
planktonic studies. Considering that there are recent examples of different bacterial
species including B. subtilis, P. aeruginosa, and Caulobacter crescentus (204) that
sense the constituents of the biofilm matrix and regulate specific genetic programs within
the biofilm cells, S. aureus may also undergo a similar process to utilize the Sae system
to sense eDNA concentrations with ECM to trigger a dispersal mechanism.
Another obvious question that can easily be addressed is how many different
Sae-regulated genes demonstrate similar expression patterns within a biofilm when
compared to nuclease? This can addressed by constructing additional dual fluorescent
promoter fusion constructs of Sae-controlled genes such as hla, hlb, fnbA, efb, P1sae,
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sbi, fib and cap, and then moving these constructs into the sae mutant backgrounds and
evaluating the effects that they have on expression within a developing biofilm. Indeed,
these constructs are currently being generated in the laboratory. In combination with this
method, our laboratory is also attempting to remove the biofilms from the microfluidic
channels by using enzymatic destruction of the biofilm matrix, and then conducting
fluorescence-activated cell sorting flow cytometry to not only count the number of
fluorescently positive cells, but to also sort the cells for further transcriptomic and
proteomic analyses. Considering that there are two target classes of Sae regulation that
rely on the phosphorylation of SaeS, we hypothesize that not all of the Sae-controlled
genes will be demonstrate stochastic expression in a subpopulation of cells like
nuclease. However, we predict that genes in the same Sae target class will demonstrate
similar expression patterns.

Tower Maturation
The studies presented here provide further confirmation that biofilms are
multicellular communities that contain both physiologic and metabolic heterogeneity.
Perhaps, one of the most obvious examples of heterogeneity in S. aureus biofilm
development is the tower maturation stage. It is in this stage where two distinct tower
types are formed. First, following the exodus stage, there are the large tower types that
rapidly divide from a distinct to foci to form large robust structures. Within these
developing towers, we observed differential regulation of the cell death operons, cidABC
and lrgAB. More specifically, the large towers demonstrated constitutive expression of
the lrgAB operon throughout the entire time of development. Conversely, cidABC
expression was not observed until the tower reached a particular robust size, at which
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point, expression was seen within the most internal regions of the tower. We
hypothesized that this internal cid expression was due to hypoxic conditions with the
tower structure. Thus, we tested an ldh1 reporter fusion, known to be expressed under
hypoxic conditions, to determine similar expression patterns. This suggested an intimate
connection with the metabolic status of the cell within the towers. In addition to the large
tower types, there were was also the emergence of small tower types that developed
from distinct foci of cells also. However, the small towers appeared to be less cohesive
and grew more slowly when compared to their larger counterparts. In addition, these
smaller tower types constitutively expressed cid, but interestingly, did not express lrg,
suggesting another form of differential regulation. Strikingly, cell death and eDNA were
only observed in the large tower types.
Given the intimate relationship that these operons have shown with the metabolic
status of the cell, in particular overflow metabolism, we hypothesize that these
expression differences are in response to metabolic status in the cells. In support of this
when we evaluated mutations Pta-AckA pathway, we saw increased cid expression as
well as the increased prevalence of small towers. Expanding upon these data, a recent
study from our laboratory also demonstrated a direct relationship with acid stress and S.
aureus biofilm formation. Under the BioFlux biofilm conditions, there were no
distinguishable differences in biofilm morphology between mutations in either the cid or
lrg operons. However, under other flow cell conditions there was a clear connection in
tower formation and regulation of cell death genes, cidC and alsSD, both of which are
regulated by the CidR regulon, (103). In addition to this, another study from the
laboratory showed that genetic mutations effecting the signal transduction of the LytSR
two-component, the primary regulator of lrgAB, developed unique biofilm characteristics
(101).
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Considering the close relationship with cid and lrg operons and the effects seen
on S. aureus biofilm development, one would think that an obvious way to evaluate the
effects of metabolism on these cell death operons would be to delete genes encoding
important enzymes in key metabolic pathways. However, this produces a couple of
caveats when looking at biofilm formation. One, deletion of metabolic enzymes often has
significant grown defects, making it extremely difficult to compare biofilm morphologies
of mutants to wild-type. Two, S. aureus is very adaptable organism and has several
ways to obtain and utilize carbon to ensure survival; therefore, mutating one metabolic
enzyme may cause a shift in carbon to another pathway making it difficult to determine
differences in biofilm formation. Last, some metabolic enzymes are essential to the
growth of the organism and cannot be disrupted. To circumvent these caveats, we are
currently designing fluorescent promoter reporter fusions to key enzymes involved in
carbon metabolism. Although these may not provide a direct indication of activity of
these enzymes, they can provide insight in to where these enzymes are being
expressed and whether or not they correlate with the expression of cid and lrg during
biofilm formation. Additionally, if cells expressing these reporter fusions linked to
metabolic enzymes can be sorted using flow cytometry, transcriptomic and proteomic
analyses may be performed to provide further insight to protein production and activity.
In conjunction with fluorescent reporters, the use of stains or dyes that indicate the
metabolic state of the cell are also currently being considered to aid in determining the
metabolism within a developing biofilm.
Another interesting question is why does S. aureus want to form towers?
Typically, we think of thicker biofilms as being more resistant to antibiotics and other
antimicrobials. While this is usually the case, there is some data in other bacterial
species like Pseudomonas species suggesting that formation of tower-like structures in
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aid in resistance to antimicrobials (211). Hence, we are also currently designing
experiments to test the resistance of cells within the towers to antibiotics or other
antimicrobials.
In conclusion, the standardization of the BioFlux1000 microfluidic flow-cell
system to cultivate S. aureus biofilms has provided unprecedented views of the stages
of biofilm development in real-time manner. The results of these studies also further
demonstrate the unique multicellular and heterogeneity characteristics of S. aureus
biofilms. Clearly, there is much more to be learned about the regulation of the Saecontrolled nuclease-mediated exodus event and the signal that triggers nuclease
expression as well as the metabolic heterogeneity that determines the expression of the
cidABC and lrgAB operons. Still, these studies have laid the fundamental groundwork for
further studies to expand upon these fascinating processes in hope of a better
understanding S. aureus biofilm development to create novel anti-biofilm therapeutic
strategies.
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